Other pleural conditions

J10_PLEUROTH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J94 Hospital discharge: ICD-9 — 511 Hospital discharge: ICD-8 — 511 Hospital discharge: excluded ICD-9 — 5111 Hospital discharge: excluded ICD-8 — 511[1-2] Cause of death: ICD-10 — J94 Cause of death: ICD-9 — 511 Cause of death: ICD-8 — 511 Cause of death: excluded ICD-9 — 5111 Cause of death: excluded ICD-8 — 511[1-2] 2 out of 7 registries used, show all original rules.	4391
4. Check minimum number of events None	4391
5. Include endpoints None	4391
6. Filter based on genotype QC (FinnGen only)	4261

Control definitions (FinnGen only)

Control exclude: J10_PLEURA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J90-J94
Name in latin: Aliae morbositates pleurae

NAME	J10_PLEUROTH
CONTROL_EXCLUDE	J10_PLEURA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J94
HD_ICD_9	511
HD_ICD_8	511
HD_ICD_10_EXCL
HD_ICD_9_EXCL	5111
HD_ICD_8_EXCL	511[1-2]
COD_MAINONLY
COD_ICD_10	J94
COD_ICD_9	511
COD_ICD_8	511
COD_ICD_10_EXCL
COD_ICD_9_EXCL	5111
COD_ICD_8_EXCL	511[1-2]
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other pleural conditions based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	35764	13302	21866
Only index persons	25352	10084	15268
Unadjusted period prevalence (%)
Whole population	0.53	0.38	0.61
Only index persons	0.50	0.37	0.58
Median age at first event (years)
Whole population	67.99	70.47	66.53
Only index persons	68.38	70.79	66.78

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4261	1460	2801
Unadjusted period prevalence (%)	1.02	0.52	1.28
Median age at first event (years)	68.15	68.15	68.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4391: Matched controls
43910

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R06.0

ICD-10 Finland

Dyspnoea

3.3

313.2

1862

8002

J94.9

ICD-10 Finland

Pleural condition, unspecified

8086.7

307.7

695

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

67.4

307.7

181

GD1AD

NOMESCO Finland

Thorax CT examination

6.2

307.7

633

1155

5119X

ICD-9 Finland

Pleurisy, Unspecified pleural effusion

+∞

307.7

382

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

27.9

307.7

1057

493

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

44.4

307.7

476

120

UGC12

NOMESCO Finland

Flexible bronchoscopy

5.1

307.7

805

1852

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

18.9

307.7

551

331

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

44.8

307.7

668

175

J94.2

ICD-10 Finland

Haemothorax

885.4

307.7

403

TGA30

NOMESCO Finland

Thoracocentesis

149.5

307.7

319

J94.8

ICD-10 Finland

Other specified pleural conditions

5820.9

307.7

2605

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

223.1

307.7

311

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1736.1

307.7

1491

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.3

306.6

2863

15927

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

6.1

296.0

559

1026

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.1

295.4

976

2851

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.5

290.6

1381

5141

C03CA01

ATC

furosemide; systemic

3.0

281.8

2465

12998

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

58.7

273.2

153

C45.0

ICD-10 Finland

Mesothelioma of pleura

75.5

258.7

139

Z51.5

ICD-10 Finland

Palliative care

4.1

252.7

820

2346

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.9

252.1

1952

9481

J86.9

ICD-10 Finland

Pyothorax without fistula

18.5

251.5

202

114

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.8

248.5

896

2758

5110B

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]

+∞

246.2

234

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.4

226.6

628

1591

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

13.9

223.7

209

157

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

43.9

221.8

132

JN4AD

NOMESCO Finland

Body CT examination

3.6

215.4

832

2664

N02AA05

ATC

oxycodone; systemic

2.9

204.5

1354

5931

I50.9

ICD-10 Finland

Heart failure, unspecified

2.8

188.7

1284

5671

JN4BD

NOMESCO Finland

Extensive body CT

3.3

187.7

827

2861

J96.1

ICD-10 Finland

Chronic respiratory failure

898.9

177.4

173

GAC00

NOMESCO Finland

Biopsy of pleura

313.3

177.4

179

A03FA01

ATC

metoclopramide; systemic, rectal

2.7

174.2

1264

5736

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

5.0

168.1

384

826

H02AB02

ATC

dexamethasone; systemic

3.2

163.3

759

2696

H02AB06

ATC

prednisolone; systemic

2.3

151.4

2397

15181

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.9

151.2

882

3548

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.5

149.2

383

905

A04AA01

ATC

ondansetron; systemic, rectal

3.6

146.5

537

1639

130

Kela drug reimbursment

Malignant tumour

3.0

143.9

719

2651

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

20.9

140.1

106

J01MA14

ATC

moxifloxacin; systemic

3.2

133.5

602

2086

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.3

131.6

364

909

R18

ICD-10 Finland

Ascites

6.3

130.0

223

367

GAC01

NOMESCO Finland

Endoscopic biopsy of pleura

226.7

128.6

132

51101

ICD-8 Finland

Pleurisy, Adhaesiones pleurae

+∞

127.7

122

I50.0

ICD-10 Finland

Congestive heart failure

2.9

124.9

698

2724

J01MA12

ATC

levofloxacin; systemic

2.3

121.7

1149

5759

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.7

121.4

789

3325

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

121.4

806

3433

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

6.4

120.6

204

331

J92.9

ICD-10 Finland

Pleural plaque without asbestos

177.7

116.0

121

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

51.5

114.8

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

114.6

1224

6439

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

114.5

1216

6382

C03DA01

ATC

spironolactone; oral

2.5

112.2

834

3740

GAA31

NOMESCO Finland

Thoracoscopy

27.6

111.9

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.9

108.5

247

527

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

6.5

106.5

178

285

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

4.1

102.3

298

771

TGC00

NOMESCO Finland

Bronchial lavation

5.4

99.8

204

396

WX892

NOMESCO Finland

Monitored bed care

2.9

97.8

516

1939

L01CA04

ATC

vinorelbine; systemic

9.8

95.3

111

116

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

91.5

418

1447

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

7.0

90.3

139

204

ZX120

NOMESCO Finland

Intravenous

2.6

87.7

563

2334

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

10.8

87.4

A04AA02

ATC

granisetron; systemic, transdermal

3.1

86.5

382

1295

R02

ICPC

Shortness of breath/dyspnoea

2.4

85.9

709

3302

1240

FHL

Bronchoscopy

6.4

83.7

140

224

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.0

82.8

390

1372

51109

ICD-8 Finland

Pleurisy, Sicca NUD

+∞

82.5

J94.0

ICD-10 Finland

Chylous effusion

+∞

82.5

N02AA01

ATC

morphine; systemic, rectal

4.9

82.2

185

390

J96.0

ICD-10 Finland

Acute respiratory failure

126.8

81.2

R03BB04

ATC

tiotropium bromide; inhalant

2.4

80.8

649

2981

9050/3-C38.4

ICD-O-3

Mesothelioma, malignant of pleura, NOS

38.1

79.3

WW500

NOMESCO Finland

Blood transfusion

3.4

78.3

290

882

WF049

NOMESCO Finland

Radiotherapy of metastasis

3.6

77.9

271

791

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.1

77.3

348

1192

R50.9

ICD-10 Finland

Fever, unspecified

2.2

77.1

786

3983

L03AA13

ATC

pegfilgrastim; parenteral

3.6

75.7

257

738

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

74.5

1069

6139

S27.1

ICD-10 Finland

Traumatic haemothorax

9.6

74.0

J94.1

ICD-10 Finland

Fibrothorax

730.4

73.4

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

73.4

1236

7486

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

6.0

73.3

131

224

TK800

NOMESCO Finland

Hemodialysis

4.6

72.5

175

391

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.0

72.4

111

162

R03AC02

ATC

salbutamol; inhalant

1.8

71.9

2160

15558

B01AB05

ATC

enoxaparin; parenteral

1.8

71.5

1521

9899

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.0

68.3

313

1081

WZC00

NOMESCO Finland

Treatment plan or consultation

1.8

67.8

1498

9825

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

67.3

1438

9332

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

67.0

591

2812

J93.8

ICD-10 Finland

Other pneumothorax

+∞

66.8

B01AA03

ATC

warfarin; systemic

1.8

66.1

1310

8303

A02BC02

ATC

pantoprazole; systemic

1.8

66.0

2938

23403

C56

ICD-10 Finland

Malignant neoplasm of ovary

11.5

65.6

1501

Kela drug reimbursment

Palbociclib

12.5

65.0

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

64.6

316

1132

C07AB07

ATC

bisoprolol; oral

1.7

64.4

2490

19006

B01AB10

ATC

tinzaparin; parenteral

2.3

63.8

518

2376

B03XA02

ATC

darbepoetin alfa; parenteral

4.1

63.2

175

435

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

61.6

1543

10425

394

Kela drug reimbursment

Palbociclib

12.4

60.7

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

60.4

1442

9601

ZXD05

NOMESCO Finland

Urgent procedure

1.8

60.1

1396

9219

R84

ICPC

Malignant neoplasm bronchus/lung

11.2

59.7

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.2

59.7

164

405

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

+∞

59.5

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

58.9

475

2169

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

6.4

58.9

156

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

6.9

58.5

135

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

9.1

58.1

A06AH03

ATC

naloxegol; oral

5.2

57.1

118

231

J98.1

ICD-10 Finland

Pulmonary collapse

104.8

56.9

J93.9

ICD-10 Finland

Pneumothorax, unspecified

290.5

56.4

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

56.2

445

2015

128

Kela drug reimbursment

Cancers of female genital organs

5.2

56.0

115

224

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

55.9

1144

7256

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.7

55.7

181

504

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

4.0

54.9

159

408

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

544.8

54.7

XG410

NOMESCO Finland

Flow-volume spirometry

3.2

54.3

223

721

WX872

NOMESCO Finland

Intensive care

2.7

54.3

314

1227

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

54.1

1973

14582

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

52.9

798

4599

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

52.9

604

3162

9052/3-C38.4

ICD-O-3

Epithelioid mesothelioma, malignant of pleura, NOS

524.2

52.6

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.6

52.2

316

1262

WZC30

NOMESCO Finland

Teaching

1.9

52.2

718

4012

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

6.1

52.0

149

JN4CD

NOMESCO Finland

Very extensive body CT

3.0

51.9

244

853

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

14.4

51.9

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

4.1

51.5

143

356

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.2

50.3

206

665

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

50.2

870

5229

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.5

49.6

173

505

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.4

49.5

371

1637

N05CF01

ATC

zopiclone; oral

1.6

49.5

1524

10730

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

15.7

48.6

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.0

48.1

218

747

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.6

47.8

291

1165

N02AX02

ATC

tramadol; systemic, rectal

1.6

47.8

1902

14218

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

47.6

652

3629

192

Kela drug reimbursment

Fulvestrant

9.8

47.4

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

5.7

47.3

160

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.7

47.1

110

239

127

Kela drug reimbursment

Transplant complication

5.4

46.1

171

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.4

46.1

116

268

S22.4

ICD-10 Finland

Multiple fractures of ribs

3.6

45.9

155

443

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

45.7

554

2954

L03AA14

ATC

lipegfilgrastim; parenteral

4.6

45.5

108

238

D38.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pleura

16.7

45.3

L01EF01

ATC

palbociclib; oral

14.3

45.1

I50.1

ICD-10 Finland

Left ventricular failure

2.3

45.0

357

1613

J01FF01

ATC

clindamycin; systemic

1.7

44.9

1128

7499

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

44.7

543

2896

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

9.0

44.6

L04AA06

ATC

mycophenolic acid; systemic

4.7

44.6

104

226

L02BA03

ATC

fulvestrant; parenteral

8.2

44.4

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

43.8

855

5299

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.5

42.9

105

237

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.2

42.7

172

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

4.0

42.5

124

320

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

3.7

42.5

138

384

A04AA55

ATC

palonosetron, combinations; systemic

3.5

42.4

149

437

M05BX04

ATC

denosumab; parenteral

2.3

42.1

322

1431

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.2

42.1

168

534

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.1

42.0

181

602

L01XE33

ATC

[U] palbociclib

13.0

41.7

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.6

41.7

143

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

41.6

475

2476

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.3

41.3

159

494

N18.8

ICD-10 Finland

Other chronic renal failure

3.0

40.9

184

627

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

40.8

759

4630

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

40.0

633

3677

R4190

NOMESCO Finland

Nutritional therapy

3.2

40.0

166

540

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

39.9

661

3893

L03AA02

ATC

filgrastim; parenteral

3.1

39.8

168

552

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

38.9

293

1293

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

3.3

38.3

150

471

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

11.2

38.0

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

5.8

38.0

120

A11CC03

ATC

alfacalcidol; systemic

3.1

37.8

159

521

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.9

37.8

187

672

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

8.4

36.8

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

36.8

505

2799

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

8.8

36.6

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

36.5

226

911

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

36.5

692

4233

WF004

NOMESCO Finland

Palliative radiotherapy

3.2

36.3

146

466

R04.2

ICD-10 Finland

Haemoptysis

2.6

36.1

218

868

SPAT1062

SPAT

Lung clearance therapy

9.6

35.9

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

35.9

1189

8383

N03AX16

ATC

[U] pregabalin

1.6

35.7

950

6354

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.9

35.7

110

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.9

35.6

455

2461

A28

ICPC

Limited function/disability NOS

1.6

35.4

943

6307

AA1AD

NOMESCO Finland

CT of head and brain

1.5

35.4

1310

9464

I50

ICD-10 Finland

Heart failure

2.5

34.9

222

907

SPAT1269

SPAT

Other puncture and/or drainage

6.8

34.8

C01AA05

ATC

digoxin; systemic

1.8

34.7

557

3240

5118X

ICD-9 Finland

Pleurisy, Other specified forms of effusion, except tuberculous

+∞

34.4

J96.9

ICD-10 Finland

Respiratory failure, unspecified

57.6

34.2

A06AD11

ATC

lactulose; oral

1.7

34.1

827

5399

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

8.1

33.7

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.4

33.7

238

1020

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

8.8

33.7

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.1

33.4

341

1702

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.5

33.1

114

330

SPAT1254

SPAT

Administration of medicine

1.7

33.1

707

4460

Z2446

NOMESCO Finland

Social worker

2.2

32.7

278

1291

XG466

NOMESCO Finland

Sleep oxymetry

3.0

32.1

146

501

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

9.8

32.1

A12AA04

ATC

calcium carbonate; oral

3.6

31.9

106

300

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

31.8

253

1142

5861

FHL

Pleural biopsy or removal of local change

88.3

31.7

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.3

31.7

247

1105

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

31.6

759

4933

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.8

31.6

251

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

4.0

31.5

229

A46

ICD-10 Finland

Erysipelas

1.7

31.5

709

4531

L02BG04

ATC

letrozole; oral

2.4

31.4

230

1002

JAL30

NOMESCO Finland

Omentectomy

5.2

31.1

125

WX725

NOMESCO Finland

Noninvasive ventilation

2.4

31.0

219

938

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

4.5

31.0

168

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

31.0

180

703

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.3

31.0

244

1097

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.1

30.9

215

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.9

30.5

143

499

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

30.5

372

1978

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

30.2

305

1515

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.4

30.2

176

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

30.1

240

1085

J01DB01

ATC

cefalexin; oral

1.5

29.9

3247

28682

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

5.1

29.8

126

L04AX01

ATC

azathioprine; systemic

2.7

29.4

167

645

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

29.4

267

1272

ZXE00

NOMESCO Finland

One hour or less

1.5

29.3

1525

11718

TJA10

NOMESCO Finland

Laparocentesis

10.1

29.2

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

4.1

29.1

198

R4110

NOMESCO Finland

Physiotherapy

1.5

29.1

1120

8098

L04AD02

ATC

tacrolimus; systemic

5.7

28.6

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.7

28.6

241

M04AA01

ATC

allopurinol; systemic

1.6

28.5

756

5024

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

3.8

28.3

229

Z3231

NOMESCO Finland

Registered nurse

1.5

28.0

1155

8461

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.2

27.9

P01BA02

ATC

hydroxychloroquine; oral

2.0

27.7

306

1570

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.0

27.5

125

429

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

27.4

237

1107

K77

ICPC

Heart failure

2.7

27.3

148

559

115

Kela drug reimbursment

Breast cancer

2.1

27.2

279

1392

A04AD12

ATC

aprepitant; systemic

3.6

27.2

254

N02BE01

ATC

paracetamol; systemic, rectal

1.6

27.1

3605

32767

L01BC06

ATC

capecitabine; oral

2.4

27.1

194

837

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

27.0

1317

9956

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

27.0

233

1088

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.4

26.9

280

J01CA04

ATC

amoxicillin; systemic

1.5

26.8

3068

27011

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

6.0

26.8

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

26.7

329

1753

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.9

26.6

124

432

N18.0

ICD-10 Finland

End-stage renal disease

3.8

26.3

213

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

3.0

26.3

115

386

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2.4

26.3

177

742

R95

ICPC

Chron obstructive pulmonary disease

2.6

26.3

156

616

WX882

NOMESCO Finland

High dependency care

2.7

26.3

143

541

SPAT1263

SPAT

Sampling

1.4

26.1

1613

12717

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

3.7

26.1

228

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.1

26.1

243

1169

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

5.0

26.0

114

L02BA01

ATC

tamoxifen; oral

2.6

25.9

148

574

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

25.7

214

984

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.4

25.7

147

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

25.7

1658

13166

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

25.7

720

4837

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.1

25.7

109

360

TK810

NOMESCO Finland

Hemofiltration

5.6

25.3

JN6AD

NOMESCO Finland

CT of torso and neck

3.5

25.3

257

207

Kela drug reimbursment

Chronic arrhythmias

1.5

25.1

849

5946

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.8

25.1

394

2269

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.2

25.0

100

319

V03AE01

ATC

polystyrene sulfonate; oral

3.3

24.8

290

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

24.8

552

3503

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

4.0

24.7

173

SPAT1262

SPAT

Handing over of treatment supplies

1.5

24.6

786

5432

Z57.2

ICD-10 Finland

Occupational exposure to dust

22.0

24.3

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.1

24.2

229

1108

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

24.1

240

1184

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

24.0

272

1407

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.2

23.9

210

987

V03AE02

ATC

sevelamer; oral

6.4

23.9

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

23.8

1452

11375

C38.4

ICD-10 Finland

Malignant neoplasm: Pleura

31.2

23.7

GAC10

NOMESCO Finland

Removal of foreign body from pleural cavity

241.3

23.7

Z94.0

ICD-10 Finland

Kidney transplant status

4.4

23.4

133

137

Kela drug reimbursment

Uraemia requiring dialysis

4.5

23.3

129

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

23.3

699

4762

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.9

23.0

108

378

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

6.5

23.0

GAC37

NOMESCO Finland

Endoscopic chemical pleurodesis

+∞

22.9

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

22.8

231

1147

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

22.8

422

2546

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.5

22.8

145

593

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

22.7

292

1577

A10AB05

ATC

insulin aspart; parenteral

1.8

22.7

343

1950

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

22.7

296

1606

R53

ICD-10 Finland

Malaise and fatigue

1.5

22.6

947

6911

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

4.2

22.6

145

H02AB07

ATC

prednisone; oral

1.6

22.6

565

3687

J01AA02

ATC

doxycycline; systemic

1.4

22.5

3073

27395

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

22.5

199

939

GA2AT

NOMESCO Finland

Pleural biopsy with ultrasound guidance

32.4

22.4

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

3.3

22.4

258

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

2.2

22.2

189

877

Z3226

NOMESCO Finland

Physiotherapist

1.5

22.1

719

4980

S27.0

ICD-10 Finland

Traumatic pneumothorax

4.6

21.9

115

N05BA04

ATC

oxazepam; oral

1.5

21.9

992

7345

3AC01, ,

NOMESCO Finland

4.2

21.8

136

A07AA09

ATC

vancomycin; oral

3.4

21.8

237

A79

ICPC

Malignancy NOS

3.1

21.8

303

QBC00

NOMESCO Finland

Removal of foreign body from skin of trunk or subcutaneous tissue

25.2

21.7

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.9

21.5

Z49.2

ICD-10 Finland

Other dialysis

4.8

21.5

101

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

2.3

21.5

169

760

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

21.4

269

1441

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

21.4

190

898

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

3.4

21.3

221

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.1

21.3

218

1087

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.7

21.2

102

SPAT1255

SPAT

Intravenous administration of medicine

1.8

21.2

307

1722

01220

ICD-8 Finland

Other respiratory tuberculosis, Pleurisy with effusion without mention of cause

9.0

21.2

WX730

NOMESCO Finland

Conventional respirator

3.3

21.1

252

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.3

21.0

238

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.6

20.9

123

485

5111B

ICD-9 Finland

Pleurisy, With effusion, with mention of a bacterial cause other than tuberculosis[PLEURITIS EXSUDATIVA ALIA DEFINITA]

+∞

20.8

R03BB01

ATC

ipratropium bromide; inhalant

2.0

20.8

228

1166

HA1AA

NOMESCO Finland

X-ray mammography

2.0

20.7

233

1203

C50.99

ICD-10 Finland

Breast, unspecified

2.8

20.6

106

390

TGA10

NOMESCO Finland

Needle biopsy of pleura

110.6

20.6

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

2.5

20.5

135

561

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

3.4

20.5

222

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

20.4

170

783

B03XA01

ATC

erythropoietin; parenteral

3.7

20.3

171

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

20.1

1326

10458

C01BD01

ATC

amiodarone; systemic

2.2

20.1

163

742

J01FA06

ATC

roxithromycin; oral

1.4

20.1

1460

11699

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.5

20.1

GAC36

NOMESCO Finland

Chemical pleurodesis

+∞

19.8

R11

ICD-10 Finland

Nausea and vomiting

1.8

19.7

328

1918

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

6.3

19.7

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

19.7

203

1015

HAC20

NOMESCO Finland

Total mastectomy

2.4

19.6

138

591

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.4

19.6

113

B05DA

ATC

Isotonic solutions

4.6

19.6

101

B01AB04

ATC

dalteparin; parenteral

2.0

19.6

231

1212

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.8

19.6

339

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.8

19.6

100

367

AN1

Coronary angiography

1.5

19.5

591

4021

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

3.1

19.5

275

5010A

ICD-9 Finland

Asbestosis[ASBESTOSIS]

24.7

19.5

S97

ICPC

Chronic ulcer skin

1.8

19.5

294

1670

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

19.5

670

4685

B05DB

ATC

Hypertonic solutions

4.7

19.4

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

3.6

19.3

172

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

8.4

19.3

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

3.5

19.1

183

S22.3

ICD-10 Finland

Fracture of rib

1.8

19.0

315

1840

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

18.9

1237

9724

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.5

18.9

184

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

18.9

418

2640

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

4.5

18.9

100

GAA97

NOMESCO Finland

Other thoracoscopic drainage procedures on pleura

34.5

18.9

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

18.7

1138

8839

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

3.6

18.6

167

0120X

ICD-9 Finland

Other respiratory tuberculosis, Tuberculous pleurisy[TUBERCULOSIS PLEURAE, EPÄILTY]

100.5

18.6

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.7

18.5

355

2159

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

18.5

195

983

R81

ICPC

Pneumonia

2.2

18.5

160

748

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

5.7

18.5

L04AA01

ATC

[U] ciclosporin

3.6

18.4

173

GAC47

NOMESCO Finland

Endoscopic partial decortication of pleura

25.1

18.2

TGD00

NOMESCO Finland

Needle biopsy of lung

5.6

18.2

L02BG06

ATC

exemestane; oral

3.4

18.2

189

L04AX03

ATC

methotrexate; systemic

1.7

18.0

318

1891

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

18.0

232

1254

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

15.3

17.9

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

5.1

17.9

WW200

NOMESCO Finland

Immunization

2.6

17.9

106

420

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

17.8

341

2073

51120

ICD-8 Finland

Pleurisy, Other specified forms of effusion, except tuberculous

+∞

17.7

GAC46

NOMESCO Finland

Partial decortication of pleura

20.1

17.7

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

2.4

17.7

124

531

R03BA01

ATC

beclometasone; inhalant

1.5

17.6

510

3432

R03BA05

ATC

fluticasone; inhalant

1.5

17.6

600

4182

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

6.3

17.5

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.8

17.5

264

1499

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

4.1

17.5

115

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

15.6

17.5

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

4.2

17.4

111

J86.00

ICD-10 Finland

Empyema with broncho-pleural fistula

17.0

17.4

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.9

17.3

273

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

17.2

590

4115

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.3

17.2

131

582

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

5.8

17.1

JAH01

NOMESCO Finland

Laparoscopy

2.2

17.1

139

635

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

17.0

203

1069

R82

ICPC

Pleurisy/pleural effusion

31.6

17.0

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

17.0

456

3017

L28

ICPC

Limited function/disability (L)

1.4

17.0

793

5872

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.7

17.0

326

GAC96

NOMESCO Finland

Other operation on pleura

25.7

16.9

XF404

NOMESCO Finland

Ambulatory ECG

1.6

16.9

390

2489

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.6

16.7

386

C01DA14

ATC

isosorbide mononitrate; oral

1.4

16.7

925

7051

WX722

NOMESCO Finland

PEEP

2.0

16.7

191

992

R60.0

ICD-10 Finland

Localized oedema

1.5

16.7

517

3530

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

16.6

1145

9041

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

16.6

685

4954

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.9

16.6

L04AD01

ATC

ciclosporin; systemic

3.1

16.6

221

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

4.8

16.6

TK820

NOMESCO Finland

Peritoneal dialysis

5.3

16.5

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

2.4

16.5

118

510

J98.6

ICD-10 Finland

Disorders of diaphragm

170.6

16.5

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

2.7

16.4

320

5862

FHL

Decortication (removal of visceral or parietal pleura)

23.1

16.4

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.8

16.3

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

4.8

16.3

N17.8

ICD-10 Finland

Other acute renal failure

3.0

16.3

244

ZX108

NOMESCO Finland

Inhalation

4.6

16.1

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

16.0

354

2233

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

15.9

115

499

A10AE04

ATC

insulin glargine; parenteral

1.6

15.9

409

2677

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.3

15.9

120

531

J01XX08

ATC

linezolid; systemic

4.4

15.9

K78

ICPC

Atrial fibrillation/flutter

1.6

15.8

414

2720

R29

ICPC

Respiratory symptom/complaint other

1.8

15.8

225

1256

GDA10

NOMESCO Finland

Biopsy of lung

7.2

15.7

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.7

15.7

277

1648

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

15.6

231

1305

N06AX11

ATC

mirtazapine; oral

1.3

15.6

1179

9428

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.4

15.6

168

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.3

15.6

113

492

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.3

15.5

111

480

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

15.5

117

518

H02AB04

ATC

methylprednisolone; systemic

1.5

15.4

521

3620

GX1K5

NOMESCO Finland

Diffusion capacity

5.7

15.4

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

15.4

133

623

R06AE07

ATC

cetirizine; oral

1.3

15.4

1360

11121

N19

ICD-10 Finland

Unspecified kidney failure

1.9

15.3

199

1079

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.2

15.3

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.6

15.3

141

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

15.2

293

1786

J01MA02

ATC

ciprofloxacin; systemic

1.3

15.1

1626

13653

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

2.3

15.1

118

531

WX002

NOMESCO Finland

Sedation and analgesia

1.4

15.0

760

5696

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

14.9

307

1903

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

14.8

116

522

SPAT1056

SPAT

Pleural puncture

31.8

14.8

9051/3-C38.4

ICD-O-3

Fibrous mesothelioma, malignant of pleura, NOS

56.9

14.8

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

14.8

388

2552

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.8

14.7

270

R03AK08

ATC

formoterol and beclometasone; inhalant

2.1

14.7

136

654

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.0

14.7

166

859

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

14.7

2424

21475

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

14.7

281

1708

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

14.7

587

4215

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.6

14.7

362

5414

UJF32

NOMESCO Finland

Coloscopy

1.3

14.6

1055

8363

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.5

14.6

352

GAC30

NOMESCO Finland

Artificial pneumothorax

+∞

14.6

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.7

14.6

277

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

2.3

14.6

105

456

Z2221

NOMESCO Finland

Medical doctor

1.4

14.5

982

7708

X76

ICPC

Malignant neoplasm breast female

2.9

14.5

239

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

3.4

14.5

151

J98.4

ICD-10 Finland

Other disorders of lung

36.1

14.4

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

14.4

360

2342

R03AC12

ATC

salmeterol; inhalant

1.8

14.3

197

1089

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.0

14.3

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.5

14.3

338

L01BA01

ATC

methotrexate; systemic

2.1

14.3

132

635

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.7

14.2

269

1630

196

Kela drug reimbursment

Paricalcitol and cinacalcet

5.3

14.2

M05BA04

ATC

alendronic acid; oral

1.6

14.1

347

2246

191

Kela drug reimbursment

Erlotinib

6.4

14.1

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.9

14.0

222

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

13.9

198

1106

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

13.8

510

3602

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

13.8

288

1790

1BA04, ,

NOMESCO Finland

17.6

13.8

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

13.8

173

928

ZX112

NOMESCO Finland

Subcutaneous

2.4

13.7

412

C07AB02

ATC

metoprolol; systemic

1.3

13.7

981

7758

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

13.6

575

4166

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.8

13.6

253

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

4.2

13.6

1500

FHL

Thoracoscopy

75.4

13.6

R28

ICPC

Limited function/disability (R)

3.0

13.6

199

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

13.5

233

1376

5110A

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURITIS SICCA]

+∞

13.5

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

+∞

13.5

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

4.8

13.5

WPB10

NOMESCO Finland

Making a convalescent care decision

5.4

13.5

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

4.7

13.5

C09AA05

ATC

ramipril; oral

1.3

13.5

1173

9534

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.7

13.4

226

1326

WVA20

NOMESCO Finland

Medicine administration

2.3

13.4

101

447

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

13.4

1348

11169

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

13.4

282

1757

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

6.1

13.4

WX721

NOMESCO Finland

Oxygen concentrator therapy

18.3

13.3

W19

ICD-10 Finland

Unspecified fall

1.5

13.3

385

2585

I97.0

ICD-10 Finland

Postcardiotomy syndrome

4.9

13.3

A10AE05

ATC

insulin detemir; parenteral

1.8

13.3

215

1248

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.9

13.2

213

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.6

13.2

294

1859

SPAT1216

SPAT

Assessment of functional ability

1.4

13.2

689

5182

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.6

13.2

275

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.8

13.1

103

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

4.9

13.1

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.6

13.1

276

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

13.1

216

1262

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

5.5

13.0

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

3.9

13.0

A02BC05

ATC

esomeprazole; systemic

1.3

13.0

1442

12089

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

13.0

393

2664

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.3

13.0

422

E87.5

ICD-10 Finland

Hyperkalaemia

2.3

13.0

441

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

5.2

12.9

RS221, ,

NOMESCO Finland

3.0

12.9

194

R09.1

ICD-10 Finland

Pleurisy

2.8

12.9

238

R77.0

ICD-10 Finland

Abnormality of albumin

13.0

12.9

SPAT1109

SPAT

Analgesia with portable analgesic pump

3.6

12.8

119

A41.8

ICD-10 Finland

Other specified sepsis

2.3

12.8

425

NHQ40

NOMESCO Finland

Amputation of toe

2.3

12.8

400

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

5.3

12.8

N05CD07

ATC

temazepam; oral

1.4

12.7

549

3991

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.7

12.7

257

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

12.7

608

4504

R05

ICD-10 Finland

Cough

1.4

12.7

706

5363

R03BA02

ATC

budesonide; inhalant

1.4

12.7

573

4203

J92

ICD-10 Finland

Pleural plaque

70.1

12.6

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

70.1

12.6

GAC43

NOMESCO Finland

Total decortication of pleura

70.1

12.6

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.0

12.6

181

WW200, ,

SPAT

0.7

12.6

423

5954

H3603, E103,

ICD-10 Finland

4.1

12.5

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

3.0

12.5

176

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.8

12.5

191

1091

A16.5

ICD-10 Finland

Tuberculous pleurisy, without mention of bacteriological or histological confirmation

130.4

12.4

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

3.0

12.4

177

A02BC01

ATC

omeprazole; systemic

1.3

12.4

1071

8683

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

12.3

313

2042

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

3.2

12.3

147

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

2.6

12.3

273

ZXA05

NOMESCO Finland

Left side

1.3

12.3

998

8019

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

2.2

12.2

106

498

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

12.2

788

6125

NK6AN

NOMESCO Finland

Total body bone isotope imaging

2.0

12.2

131

668

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

12.1

215

1281

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

12.1

331

2195

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

12.1

599

4459

GX2C5

NOMESCO Finland

Short-lasting oximetry

6.0

12.1

E0000UV, ,

ATC

1.3

12.0

1429

12057

P01AB01

ATC

metronidazole; oral, rectal

1.3

12.0

1279

10646

3009

Kela drug reimbursment

Niraparib

21.3

12.0

1510

Kela drug reimbursment

Niraparib

21.3

12.0

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

4.2

12.0

K65.0

ICD-10 Finland

Acute peritonitis

2.7

12.0

225

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

5.0

11.9

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.1

11.9

113

550

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

11.9

1441

12184

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

2.9

11.9

187

SPAT1260

SPAT

Consultation of another employee

1.4

11.9

629

4735

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

4.8

11.9

R06.2

ICD-10 Finland

Wheezing

1.9

11.9

145

772

I34.1

ICD-10 Finland

Mitral (valve) prolapse

2.1

11.8

116

572

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

11.7

11.8

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

3.0

11.8

172

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

3.3

11.7

131

B01AF02

ATC

apixaban; oral

1.4

11.7

578

4301

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.4

11.7

322

ZXA00

NOMESCO Finland

Right side

1.3

11.7

1065

8683

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

11.7

1216

10086

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

11.7

778

6071

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.5

11.7

112

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

4.6

11.6

XGX10

NOMESCO Finland

Intrapleural ultrasonography

30.1

11.6

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

11.6

1087

8892

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.2

11.5

458

TFP20

NOMESCO Finland

Cardiodefibrillation

1.5

11.5

335

2254

TPX15

NOMESCO Finland

Removal of vascular injection port

4.8

11.4

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.1

11.4

154

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

4.7

11.4

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.1

11.4

149

R03AC13

ATC

formoterol; inhalant

1.8

11.4

181

1047

RD210, ,

NOMESCO Finland

2.7

11.3

220

SPAT1301

SPAT

No procedures

1.3

11.3

1192

9894

A04

ICPC

Weakness/tiredness general

1.4

11.3

533

3936

E87.6

ICD-10 Finland

Hypokalaemia

1.9

11.3

138

736

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

9.6

11.2

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.2

11.2

140

5188X

ICD-9 Finland

Other diseases of lung

4.3

11.2

A10AC01

ATC

insulin (human); parenteral

1.5

11.2

326

2194

197

Kela drug reimbursment

Sunitinib

4.6

11.2

J86.09

ICD-10 Finland

Pyothorax with fistula

25.1

11.1

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

11.1

1109

9141

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.7

11.1

223

ZZA00

NOMESCO Finland

Split skin graft

1.9

11.0

130

685

JAH00

NOMESCO Finland

Laparotomy

2.0

11.0

119

609

R07.3

ICD-10 Finland

Other chest pain

1.5

10.9

362

2502

H02AB09

ATC

hydrocortisone; systemic

2.3

10.9

364

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

3.8

10.9

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

3.4

10.8

108

Angiography of the heart and coronary arteries

1.5

10.8

347

2382

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.4

10.8

113

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

3.6

10.7

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

4.9

10.7

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

10.7

1551

13350

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

2.8

10.7

182

RJ411, ,

NOMESCO Finland

4.0

10.7

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.9

10.7

132

707

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

10.6

278

1827

WX704

NOMESCO Finland

Intubation

1.6

10.6

260

1684

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

10.6

1005

8224

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

8.0

10.6

Z94.4

ICD-10 Finland

Liver transplant status

8.0

10.6

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.2

10.5

428

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.4

10.5

301

WPA13

NOMESCO Finland

Palliative consultation

5.0

10.5

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.8

10.5

141

775

155

Kela drug reimbursment

Afatinib and gefitinib

10.0

10.5

K86.1

ICD-10 Finland

Other chronic pancreatitis

3.0

10.5

146

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

4.0

10.5

RS220, ,

NOMESCO Finland

3.0

10.4

157

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

+∞

10.4

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

10.4

188

1127

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.0

10.4

111

565

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

1.9

10.4

137

749

5BA08, ,

NOMESCO Finland

3.9

10.4

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

10.4

253

1636

C45.9

ICD-10 Finland

Mesothelioma, unspecified

32.6

10.3

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

10.3

358

2498

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.8

10.3

148

832

L01XK02

ATC

niraparib; oral

18.8

10.2

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.6

10.2

233

1485

I31.8

ICD-10 Finland

Other specified diseases of pericardium

13.1

10.1

R99

ICPC

Respiratory disease other

2.4

10.1

294

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.2

10.1

118

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

3.0

10.1

144

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

7.9

10.1

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

4.2

10.1

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

2.5

10.1

234

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

10.1

435

5876

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

4.3

10.0

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.8

10.0

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

3.0

10.0

150

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.1

10.0

417

W06

ICD-10 Finland

Fall involving bed

2.9

10.0

161

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

4.6

10.0

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.8

10.0

142

795

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

10.0

697

5467

B01AC04

ATC

clopidogrel; oral

1.3

10.0

782

6234

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

9.9

220

1390

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

4.0

9.9

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.8

9.9

150

855

J01DA01

ATC

[U] cefalexin

1.2

9.9

2291

20672

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.5

9.9

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.6

9.9

213

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

5.1

9.8

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.7

9.7

186

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

3.4

9.7

101

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

3.3

9.7

111

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

2.8

9.7

164

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

2.7

9.6

181

SPAT1229

SPAT

Assessment of need for aid

1.5

9.6

324

2247

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

9.6

297

2025

J05AB11

ATC

valaciclovir; oral

1.4

9.6

447

3291

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

3.0

9.6

138

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

4.4

9.5

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.0

9.5

466

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

9.5

246

1613

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

3.8

9.5

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

9.5

232

1502

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.0

9.5

474

GA2CT

NOMESCO Finland

Pleural biopsy with CT guidance

100.3

9.4

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.5

9.4

313

2165

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

2.6

9.4

195

J43.9

ICD-10 Finland

Emphysema, unspecified

2.2

9.4

323

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.6

9.4

201

5120A

ICD-9 Finland

Pneumothorax, Spontaneous tension pneumothorax

+∞

9.4

51299

ICD-8 Finland

Spontaneous pneumothorax

+∞

9.4

J98.5

ICD-10 Finland

Diseases of mediastinum, not elsewhere classified

+∞

9.4

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

4.2

9.4

L02BG03

ATC

anastrozole; oral

2.5

9.3

219

168

Kela drug reimbursment

Axitinib

21.7

9.3

306

Kela drug reimbursment

Erythropoietin and darbepoetin

4.4

9.3

R03BB02

ATC

oxitropium bromide; inhalant

2.9

9.3

151

OAB43, ,

SPAT

0.6

9.2

172

2753

A12BA01

ATC

potassium chloride; oral

1.6

9.2

219

1408

J45.8

ICD-10 Finland

Mixed asthma

2.0

9.2

102

527

RS222, ,

NOMESCO Finland

2.6

9.2

203

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.3

9.2

288

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.0

9.1

508

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

2.1

9.1

406

WX402

NOMESCO Finland

General anaesthesia

1.3

9.1

620

4842

WX726

NOMESCO Finland

High-flow oxygen therapy

11.5

9.1

R85

ICPC

Malignant neopl respiratory other

8.3

9.0

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

9.0

324

2274

I30.8

ICD-10 Finland

Other forms of acute pericarditis

15.6

9.0

3004

Kela drug reimbursment

Osimertinib

15.6

9.0

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

9.0

147

858

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

3.7

9.0

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

3.1

8.9

117

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.2

8.9

305

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

3.1

8.9

112

R03DA04

ATC

theophylline; systemic, rectal

1.5

8.9

240

1589

ZZR10

NOMESCO Finland

Flap of skin and muscle

3.3

8.9

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2.1

8.9

364

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

2.8

8.8

150

J43.2

ICD-10 Finland

Centrilobular emphysema

4.5

8.8

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.0

8.8

439

XX9XW, ,

NOMESCO Finland

3.8

8.8

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.6

8.8

204

1306

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

8.8

107

572

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

9.5

8.8

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1.8

8.7

116

637

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.5

8.7

203

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.7

8.7

174

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.0

8.7

441

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

8.7

615

4828

20199

ICD-8 Finland

Hodgkin's disease

14.0

8.7

1519, ,

Kela drug reimbursment

14.0

8.7

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

3.9

8.7

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

2.3

8.7

277

R03AK11

ATC

formoterol and fluticasone; inhalant

2.1

8.7

361

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

7.6

8.6

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

7.6

8.6

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.6

8.6

179

1116

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

8.6

454

3413

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

2.9

8.5

131

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

4.1

8.5

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

8.5

527

4058

GDG10

NOMESCO Finland

Bilateral transplantation of lung

27.6

8.5

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

8.4

871

7176

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

1.9

8.4

104

558

GDC00

NOMESCO Finland

Lobectomy of lung

3.1

8.4

106

RJ414, ,

NOMESCO Finland

4.9

8.4

R96

ICPC

Asthma

1.5

8.3

293

2049

L01XE03

ATC

[U] erlotinib

6.7

8.3

9053/3-C38.4

ICD-O-3

Mesothelioma, biphasic, malignant of pleura, NOS

+∞

8.3

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

8.3

823

6746

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.7

8.3

146

871

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.5

8.3

202

A29

ICPC

General symptom/complaint other

1.4

8.3

462

3501

Z72.0

ICD-10 Finland

Tobacco use

2.1

8.3

341

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

1.9

8.3

498

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

3.1

8.3

112

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

3.8

8.2

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

8.2

1339

11597

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.3

8.2

271

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

3.0

8.1

113

SPAT1251

SPAT

Organisation of medication

1.7

8.1

142

846

PE1AT

NOMESCO Finland

Femoral artery PTA

2.2

8.1

285

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

1.9

8.1

101

544

R2110

NOMESCO Finland

Giving the first information

1.6

8.1

176

1109

R05

ICPC

Cough

1.3

8.1

736

5968

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.0

8.1

405

I31.1

ICD-10 Finland

Chronic constrictive pericarditis

33.4

8.1

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.7

8.1

158

970

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.2

8.1

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.3

8.0

267

1243

FHL

Bronchoscopy and other therapeutic procedure

8.9

8.0

E86

ICD-10 Finland

Volume depletion

1.8

8.0

117

662

I43.1*E85.9

ICD-10 Finland

Cardiac amyloidosis

10.0

8.0

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.3

8.0

236

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

2.9

8.0

125

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

8.0

1142

9751

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.7

8.0

153

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

2.5

8.0

188

N03AX12

ATC

[U] gabapentin; oral

1.3

7.9

535

4168

Z94.1

ICD-10 Finland

Heart transplant status

7.2

7.9

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

7.9

250

1712

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

4.3

7.9

Z31.5

ICD-10 Finland

Genetic counselling

1.8

7.9

105

577

3025

Kela drug reimbursment

Calcium carbonate

3.3

7.9

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.0

7.9

388

NGQ20

NOMESCO Finland

Amputation of lower leg

2.9

7.9

126

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

7.9

282

1980

Z94.2

ICD-10 Finland

Lung transplant status

13.0

7.9

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.2

7.9

276

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

7.8

123

712

S42.0

ICD-10 Finland

Fracture of clavicle

1.9

7.8

501

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.0

7.8

424

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

2.4

7.8

202

R03AC18

ATC

indacaterol; inhalant

2.9

7.8

116

L04AA13

ATC

[U] leflunomide

2.1

7.8

336

GD1UN

NOMESCO Finland

Lung circulation SPECT

3.4

7.8

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

7.8

1368

11922

1XC02, ,

NOMESCO Finland

3.2

7.8

A02BA02

ATC

ranitidine; systemic

1.3

7.8

762

6236

E85.9

ICD-10 Finland

Amyloidosis, unspecified

6.9

7.8

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

7.8

208

1377

A10AB01

ATC

insulin (human); parenteral

1.8

7.7

112

633

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.1

7.7

324

R03AC03

ATC

terbutaline; inhalant

1.4

7.7

417

3144

GDA96

NOMESCO Finland

Other incision, excision of lesion or repair of lung

45.1

7.7

L01XE13

ATC

[U] afatinib

15.0

7.7

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

7.7

142

859

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

7.7

169

1069

A07AA02

ATC

nystatin; oral

1.5

7.7

205

1356

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

2.1

7.7

345

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

3.3

7.6

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.0

7.6

112

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

3.0

7.6

112

M34.1

ICD-10 Finland

CR(E)ST syndrome

4.5

7.6

E87.7

ICD-10 Finland

Fluid overload

11.8

7.6

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

25.0

7.6

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

7.6

198

1304

J46

ICD-10 Finland

Status asthmaticus

1.9

7.6

450

N06AB04

ATC

citalopram; systemic

1.3

7.6

669

5405

NG1AA, ,

SPAT

0.4

7.5

882

A10AA01, ,

ATC

2.0

7.5

388

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

2.6

7.5

152

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

3.5

7.5

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

10.0

7.5

K70.4

ICD-10 Finland

Alcoholic hepatic failure

3.8

7.5

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

7.5

522

ZXC40

NOMESCO Finland

Use of ultrasound

3.3

7.5

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

3.3

7.5

AA1

Conventional CABG

1.8

7.5

102

566

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

1.8

7.5

105

588

I20.00

ICD-10 Finland

Unstable angina

1.6

7.5

146

897

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

7.5

1039

8838

XG460

NOMESCO Finland

Short time oxymetry

2.1

7.5

322

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

2.6

7.4

153

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

3.1

7.4

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

4.4

7.4

156

Kela drug reimbursment

Lapatinib

80.2

7.4

C08CA01

ATC

amlodipine; oral

1.2

7.4

1609

14291

NA2AD

NOMESCO Finland

Thoracic spine CT examination

3.1

7.4

H3601, E103,

ICD-10 Finland

3.3

7.4

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.3

7.4

239

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

1.9

7.3

490

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.4

7.3

208

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

4.0

7.3

S18

ICPC

Laceration/cut

1.2

7.3

1689

15077

J01CF05

ATC

flucloxacillin; systemic

1.6

7.3

185

1210

SPAT1172

SPAT

Guidance concerning hydration

1.8

7.3

103

578

A01AB09

ATC

miconazole; local oral

1.4

7.3

290

2077

GDD20

NOMESCO Finland

Extended pneumonectomy

+∞

7.3

GAC40

NOMESCO Finland

Pleurodesis with decortication

+∞

7.3

5111A

ICD-9 Finland

Pleurisy, With effusion, with mention of a bacterial cause other than tuberculosis[PLEURITIS EXSUDATIVA BACTERICA]

+∞

7.3

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

3.6

7.3

N05BA01

ATC

diazepam; systemic, rectal

1.3

7.3

436

3339

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.1

7.3

332

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.8

7.3

528

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.2

7.3

247

ZY010

NOMESCO Finland

Hospital outpatient

1.7

7.3

113

653

R03BA08

ATC

ciclesonide; inhalant

1.5

7.2

225

1537

PJA10

NOMESCO Finland

Exploration of lymph nodes

2.4

7.2

197

E000001, ,

ATC

1.3

7.2

628

5059

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

7.2

195

1293

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.9

7.2

507

WX720

NOMESCO Finland

Own respiration

1.6

7.2

150

936

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

7.2

387

2914

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.1

7.2

333

4910A

ICD-9 Finland

Chronic bronchitis, Simple chronic bronchitis

4.3

7.2

J47

ICD-10 Finland

Bronchiectasis

2.0

7.2

347

J80

ICD-10 Finland

Adult respiratory distress syndrome

3.9

7.2

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

3.1

7.1

FE2AT

NOMESCO Finland

Pericardial cathetrisation with ultrasound guidance

30.1

7.1

X57

ICD-10 Finland

Unspecified privation

2.0

7.1

389

4019X

ICD-9 Finland

Essential hypertension, Unspecified

1.6

7.1

155

978

GAW97

NOMESCO Finland

Other thoracoscopic operation on chest wall, pleura and diaphragm

20.0

7.1

JBA10

NOMESCO Finland

Transabdominal biopsy or excision of lesion of diaphragm

20.0

7.1

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

2.6

7.1

145

R04.0

ICD-10 Finland

Epistaxis

1.4

7.1

310

2257

SPAT1234

SPAT

Support of social functional capacity

1.5

7.1

214

1453

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

2.9

7.1

106

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

7.1

397

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.1

7.1

282

N06DX01

ATC

memantine; oral

0.7

7.1

213

3074

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.7

7.1

134

198

Kela drug reimbursment

Sorafenib

4.1

7.1

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

6.0

7.1

1502

Kela drug reimbursment

Cabozantinib

6.0

7.1

WX250

NOMESCO Finland

Intercostal blockade

5.6

7.0

L01XE04

ATC

[U] sunitinib

5.6

7.0

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

5.6

7.0

D68.8

ICD-10 Finland

Other specified coagulation defects

2.8

7.0

123

I27.0

ICD-10 Finland

Primary pulmonary hypertension

8.8

7.0

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

3.0

7.0

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

2.7

7.0

129

4919X

ICD-9 Finland

Chronic bronchitis, Unspecified chronic bronchitis

4.2

7.0

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

7.0

124

743

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

2.5

7.0

158

SPAT1325

SPAT

Vaccination

1.2

7.0

1309

11454

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.0

2256

20708

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

7.0

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

1.9

7.0

477

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

3.5

7.0

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

7.0

216

1476

SPAT1310

SPAT

Counselling related to known health issue

1.2

7.0

1062

9110

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.0

7.0

372

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.2

7.0

258

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

3.3

7.0

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

4.4

7.0

H3600, E103,

ICD-10 Finland

3.0

6.9

102

ZX114

NOMESCO Finland

Intramuscular

2.4

6.9

183

PD5BD

NOMESCO Finland

Extensive CT of aorta

1.9

6.9

450

X77

ICPC

Malignant neopl genital female other

5.4

6.9

E83.50

ICD-10 Finland

Hypercalcemia

2.3

6.9

208

R03BB07

ATC

umeclidinium bromide; inhalant

2.9

6.9

108

AP3

Catheterization of the right and left side of the heart

4.0

6.9

ZX121

NOMESCO Finland

Central venous catheter

4.0

6.9

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

4.0

6.9

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.1

6.9

299

C08DB01

ATC

diltiazem; oral

1.4

6.9

261

1855

J45

ICD-10 Finland

Asthma

1.4

6.8

268

1916

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.7

6.8

126

764

J18

ICD-10 Finland

Pneumonia, organism unspecified

2.6

6.8

137

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

10.9

6.8

K92.1

ICD-10 Finland

Melaena

1.5

6.8

235

1642

ZX100

NOMESCO Finland

Oral

2.2

6.8

261

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

6.1

6.8

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.9

6.8

468

L01XE17

ATC

[U] axitinib

40.1

6.8

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.3

6.8

210

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

2.7

6.8

126

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.6

6.7

WX213

NOMESCO Finland

Lower leg blockade

2.7

6.7

132

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.2

6.7

236

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.9

6.7

469

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.5

6.7

185

1235

C45.1

ICD-10 Finland

Mesothelioma of peritoneum

22.5

6.7

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

2.4

6.7

174

N07BB01

ATC

disulfiram; oral

1.7

6.6

105

610

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

2.6

6.6

133

I51.4

ICD-10 Finland

Myocarditis, unspecified

3.7

6.6

JJC00

NOMESCO Finland

Allogenic transplantation of liver

7.8

6.6

J01FA15

ATC

telithromycin; oral

1.4

6.6

265

1903

K85

ICD-10 Finland

Acute pancreatitis

2.0

6.6

338

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

6.6

567

5822

FHL

Exploratory thoracotomy and small procedure (eg lung suture)

12.2

6.6

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.6

6.6

127

780

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

8.7

6.5

C34.35

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma

8.7

6.5

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

10.0

6.5

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

10.0

6.5

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

2.5

6.5

158

L76

ICPC

Fracture: other

1.7

6.5

102

592

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

6.5

185

1244

QDA10

NOMESCO Finland

Incision of skin of lower limb

2.8

6.5

112

SPAT1097

SPAT

Recording of ECG

1.3

6.5

540

4328

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

6.5

917

7802

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

6.2

6.5

S27.2

ICD-10 Finland

Traumatic haemopneumothorax

6.2

6.5

GD2AT

NOMESCO Finland

Cytology of the lungs with ultrasound guidance

6.2

6.5

3012

Kela drug reimbursment

Cabozantinib

5.7

6.4

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

2.0

6.4

341

L88

ICPC

Rheumatoid/seropositive arthritis

1.7

6.4

107

631

C08DA01

ATC

verapamil; systemic

1.6

6.4

157

1020

I95.9

ICD-10 Finland

Hypotension, unspecified

1.9

6.4

376

I47.2

ICD-10 Finland

Ventricular tachycardia

1.8

6.4

505

SPAT1122

SPAT

Ascites puncture

70.0

6.4

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.8

6.4

564

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.5

6.4

159

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

2.9

6.4

ED1AA

NOMESCO Finland

Mandibular X-ray examination

3.2

6.4

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

3.4

6.4

AC4

MVP

3.3

6.4

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

6.4

155

1005

K92.0

ICD-10 Finland

Haematemesis

1.7

6.4

104

610

R60.1

ICD-10 Finland

Generalized oedema

3.0

6.4

A10BH05

ATC

linagliptin; oral

1.5

6.4

217

1512

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

2.2

6.3

216

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.7

6.3

118

718

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

6.3

268

1943

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

2.3

6.3

191

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

2.2

6.3

223

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

3.6

6.3

AP2

Catheterization of the right side of the heart

3.6

6.3

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

2.1

6.3

269

5100A

ICD-9 Finland

Empyema, With fistula

11.0

6.3

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

11.0

6.3

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

11.0

6.3

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.8

6.3

494

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

6.3

2606

24323

K86.3

ICD-10 Finland

Pseudocyst of pancreas

3.3

6.3

A15.6

ICD-10 Finland

Tuberculous pleurisy, confirmed bacteriologically and histologically

18.0

6.3

X99.0

ICD-10 Finland

Assault by sharp object by spouse or partner

18.0

6.3

9650/3-C77.0

ICD-O-3

Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck

18.0

6.3

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.8

6.3

524

TQW99

NOMESCO Finland

Other minor procedure on skin

1.5

6.3

194

1327

N07BC02

ATC

methadone; systemic

3.8

6.3

C45

ICD-10 Finland

Mesothelioma

+∞

6.2

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

+∞

6.2

B03BA03

ATC

hydroxocobalamin; parenteral

1.4

6.2

248

1778

N03AG01

ATC

valproic acid; systemic, rectal

1.5

6.2

165

1092

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

2.0

6.2

311

A03

ICPC

Fever

1.3

6.2

392

3026

R07.1

ICD-10 Finland

Chest pain on breathing

2.3

6.2

199

WGA11

NOMESCO Finland

Planning of pain management

3.7

6.2

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.1

6.2

258

SPAT1211

SPAT

Application of soft bandage

1.4

6.2

291

2149

M10.2

ICD-10 Finland

Drug-induced gout

4.0

6.2

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

4.0

6.2

X58

ICD-10 Finland

Exposure to other specified factors

1.3

6.2

396

3065

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

3.5

6.1

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

3.5

6.1

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.6

6.1

149

967

R52.1

ICD-10 Finland

Chronic intractable pain

2.8

6.1

104

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.0

6.1

292

Catheterization and pressure measurement of the right side of the heart

3.2

6.1

XG405

NOMESCO Finland

Education on PEF monitoring

2.2

6.1

213

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

1.9

6.1

341

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

6.1

134

850

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

6.1

447

3523

TJD20

NOMESCO Finland

Change of gastrostomy tube

3.8

6.1

JAL00

NOMESCO Finland

Biopsy of peritoneum

3.8

6.1

D638, N188,

ICD-10 Finland

12.5

6.1

3A422, ,

NOMESCO Finland

12.5

6.1

I25.2

ICD-10 Finland

Old myocardial infarction

1.3

6.1

351

2675

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

6.1

405

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.6

6.1

139

891

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

2.6

6.0

122

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

8.6

6.0

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

8.6

6.0

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.7

6.0

552

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

2.8

6.0

105

7862A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Cough

2.8

6.0

105

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.7

6.0

154

2294

WX900

NOMESCO Finland

Resuscitation

3.1

6.0

J01DA09

ATC

[U] cefadroxil

1.2

6.0

830

7036

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

1.7

6.0

560

GDB10

NOMESCO Finland

Wedge resection of lung

6.7

6.0

158

Kela drug reimbursment

Everolimus

6.7

6.0

N06AX16

ATC

venlafaxine; oral

1.4

6.0

323

2435

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

2.3

6.0

183

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

2259

10933

3.20

309.10

6.3

4.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

1266

293

60.31

307.65

1.8

1.2

35.27

26.64

g/l

22.09

1189

245

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

679

942

8.34

307.65

1.8

1.7

—

(3042936) Bacteria identified in Isolate by Culture

1708

4848

5.13

307.65

2.6

2.0

—

(3045788) Cell count panel - Pleural fluid

815

215

46.32

307.65

1.9

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

775

102

92.05

307.65

1.4

1.1

13.42

14.87

u/l

0.20

732

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

921

171

67.89

307.65

1.5

1.1

397.08

335.16

u/l

0.57

886

160

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

950

1091

10.84

307.65

2.7

2.6

—

(40768806) Pleura Pathology biopsy report

986

201

62.97

307.65

1.9

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1433

4393

4.36

307.65

4.1

3.9

243.77

246.17

u/l

0.22

1383

4112

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

272

61.63

307.65

1.6

1.0

22.44

24.07

0.14

239

(3001893) Eosinophils/100 leukocytes in Pleural fluid

316

55.74

307.65

1.6

1.2

3.16

3.24

0.02

271

(3023199) Leukocytes [#/volume] in Pleural fluid

1087

275

52.20

307.65

1.8

1.2

2047.50

1825.38

e6/l

0.17

889

182

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

305

99.25

307.65

1.4

1.1

526.18

121.23

ug/l

1.70

167

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

767

621

14.75

307.65

1.9

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1342

3142

5.71

307.65

2.7

2.6

63.28

66.23

g/l

28.01

1274

2782

(3036782) Glucose [Moles/volume] in Pleural fluid

857

190

55.80

307.65

1.6

1.2

5.91

7.26

mmol/l

4.69

799

177

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

359

45.37

307.65

1.6

1.2

65.09

56.59

1.14

307

(3000919) Neutrophils/100 leukocytes in Pleural fluid

280

52.40

307.65

1.6

1.2

17.09

35.74

4.02

258

(3035880) pH of Pleural fluid

563

105

61.36

307.65

1.4

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

667

107

73.32

307.65

1.6

1.3

12.69

14.17

u/l

1.01

641

101

(3028308) Erythrocytes [#/volume] in Pleural fluid

983

249

50.58

307.65

1.8

1.2

70074.67

15012.40

e6/l

6.30

670

136

(3012441) Differential panel - Pleural fluid

924

220

52.93

307.65

1.9

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

168

67.15

307.08

1.6

1.2

13.17

5.27

2.20

(3041918) Cholesterol [Moles/volume] in Pleural fluid

179

46.61

304.80

1.4

1.1

1.79

1.31

mmol/l

0.63

154

(3042010) Triglyceride [Moles/volume] in Pleural fluid

166

63.86

300.88

1.4

1.0

1.99

0.82

mmol/l

—

140

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

150

59.70

268.68

1.4

1.1

60.55

2219.36

u/l

0.53

126

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

145

68.13

265.67

1.6

1.1

71.55

77.71

0.52

125

(44786800) Granulocytes/100 leukocytes in Body fluid

138

59.33

246.92

1.4

1.3

21.64

20.41

0.07

108

(3042631) Mycobacterium sp identified in Specimen

333

430

8.30

243.89

2.5

2.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1348

5762

2.93

214.62

5.1

3.0

0.80

0.81

mmol/l

3.18

1288

5329

(3022217) INR in Platelet poor plasma by Coagulation assay

2910

18303

2.75

214.16

25.6

19.1

1.41

1.38

inr

0.69

832

5039

(3014891) Appearance of Pleural fluid

122

40.45

201.00

1.5

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1389

6285

2.77

195.86

2.4

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2521

15208

2.54

194.95

9.5

5.9

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2839

18176

2.59

192.19

11.4

6.0

11.63

12.62

umol/l

3.56

2731

17206

(3019069) Monocytes/100 leukocytes in Blood

2511

15342

2.49

185.45

9.1

6.0

9.34

8.91

7.43

2405

14146

(3022096) Basophils/100 leukocytes in Blood

2448

14828

2.47

183.65

8.8

5.7

0.60

0.65

4.98

2340

13649

(3006504) Eosinophils/100 leukocytes in Blood

2492

15269

2.46

181.45

8.7

5.7

2.55

2.89

12.67

2385

14057

(3002030) Lymphocytes/100 leukocytes in Blood

2529

15651

2.45

179.31

8.9

5.8

21.64

26.32

75.43

2423

14466

(3006315) Basophils [#/volume] in Blood

2597

16267

2.46

179.18

8.3

5.4

0.04

e9/l

1.14

2325

13775

(3001604) Monocytes [#/volume] in Blood

2587

16204

2.45

178.07

8.3

5.4

0.67

0.62

e9/l

16.72

2321

13719

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

995

3949

2.96

177.44

3.4

4.1

27.07

21.54

ug/l

0.24

822

3277

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

59.56

177.20

1.1

19.61

18.22

u/l

—

(3013115) Eosinophils [#/volume] in Blood

2648

16790

2.45

176.89

8.7

5.6

0.19

0.20

e9/l

1.93

2381

14407

(3019198) Lymphocytes [#/volume] in Blood

2618

16604

2.43

173.42

8.5

5.5

1.61

1.88

e9/l

6.94

2374

14370

(3024561) Albumin [Mass/volume] in Serum or Plasma

2513

15823

2.38

166.70

8.2

4.7

31.27

34.78

g/l

134.67

2364

14560

(3013650) Neutrophils [#/volume] in Blood by Automated count

2858

19045

2.43

166.27

16.7

8.4

4.59

4.29

e9/l

6.78

2602

16402

(3018010) Neutrophils/100 leukocytes in Blood

2462

15411

2.36

164.90

8.5

5.6

62.38

58.32

47.79

2352

14241

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1258

5885

2.59

161.18

3.1

1.9

30.70

30.09

2.48

1225

5702

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2061

12171

2.31

155.38

4.7

3.0

2784.84

1804.88

ng/l

7.72

1882

10502

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

548

1641

3.67

154.22

2.2

1.8

4.34

2.74

ug/l

0.26

500

1415

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

509

1456

3.82

153.19

3.9

2.6

0.33

0.34

u/ml

0.12

312

824

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

324

670

5.14

148.20

1.5

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1085

4908

2.61

147.29

9.7

5.5

1.10

1.04

mmol/l

10.33

1030

4493

(3020779) Urea [Moles/volume] in Serum or Plasma

875

3559

2.82

146.51

12.0

6.5

12.54

11.12

mmol/l

5.03

830

3346

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2705

18277

2.25

142.16

13.0

6.6

1.20

1.21

mmol/l

16.44

2276

15448

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2507

16550

2.20

137.94

11.1

5.8

1.20

1.21

mmol/l

13.98

2341

14902

(3014111) Lactate [Moles/volume] in Serum or Plasma

832

3402

2.78

137.16

7.1

6.2

1.32

1.40

mmol/l

1.60

802

3289

(4035726) Immunohistochemistry procedure

756

2957

2.88

135.40

1.5

1.3

—

(3003396) Base excess in Arterial blood by calculation

982

4410

2.58

133.90

8.4

6.3

1.76

0.82

mmol/l

9.94

804

3380

(3027801) Oxygen [Partial pressure] in Arterial blood

980

4422

2.57

132.12

8.4

6.3

11.12

12.23

kpa

10.35

939

4184

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

980

4424

2.56

131.98

8.4

6.3

5.21

4.99

kpa

7.21

935

4187

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

249

455

5.74

130.41

1.5

2.0

23.48

25.35

ug/l

0.17

242

447

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

963

4358

2.55

128.68

2.2

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

955

4348

2.53

125.69

2.3

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1124

5543

2.38

123.88

3.8

2.5

2.11

2.26

g/l

14.73

1047

5100

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1805

10872

2.12

120.95

3.5

2.5

58.90

68.09

u/l

0.62

1695

9987

(3022948) Iron [Moles/volume] in Serum or Plasma

1177

5978

2.32

120.76

3.8

2.5

10.30

12.49

umol/l

23.54

1089

5530

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

315

752

4.44

120.59

1.8

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1073

5248

2.38

120.01

3.9

2.6

20.25

22.34

4.49

913

4426

(3019060) Gas panel - Arterial blood

645

2462

2.90

119.93

6.0

4.2

—

(3009343) pH of Capillary blood

626

2352

2.94

119.81

6.0

3.3

7.41

0.41

258

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

630

2384

2.92

118.97

6.0

3.3

5.33

5.05

kpa

10.26

609

2217

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

321

791

4.30

117.89

1.8

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

607

2264

2.95

117.61

6.0

3.3

2.75

1.47

mmol/l

12.25

492

1584

(3037522) Nuclear Ab [Titer] in Serum

813

3588

2.55

113.18

1.5

1.3

503.35

505.22

titre

0.01

221

782

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

315

802

4.15

110.65

2.0

1.4

1.07

1.18

g/l

5.07

303

755

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

307

771

4.21

109.82

1.9

1.5

0.24

g/l

0.15

295

728

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

259

571

4.76

109.37

1.9

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

249

534

4.88

108.69

1.6

1.3

—

(3016502) Oxygen saturation in Arterial blood

863

3987

2.45

108.48

8.9

6.6

94.64

95.62

3.37

840

3823

(3009445) Proteinase 3 Ab [Units/volume] in Serum

431

1393

3.32

106.32

1.3

1.4

6.14

13.63

u/ml

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

210

409

5.34

102.39

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

211

415

5.29

101.75

1.5

1.3

—

(1616796) Gas panel - Central venous blood

290

751

4.06

99.38

5.4

3.2

—

(3002032) Base excess in Venous blood by calculation

805

3741

2.41

99.08

6.5

3.6

2.03

1.72

mmol/l

1.46

686

3074

(3005719) IgG [Mass/volume] in Serum or Plasma

564

2223

2.76

97.65

3.1

2.6

10.77

10.57

g/l

0.39

522

2002

(3021447) Carbon dioxide [Partial pressure] in Venous blood

802

3749

2.39

97.27

6.6

3.6

5.98

5.76

kpa

6.35

764

3611

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

211

436

5.03

96.12

1.7

1.3

—

(3018418) pH of Serum or Plasma

1713

10773

1.97

96.04

7.5

3.9

7.40

0.28

401

1943

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

640

2710

2.59

95.97

1.9

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

654

2803

2.57

95.62

5.0

3.8

0.98

0.94

0.19

341

1018

(3012544) pH of Venous blood

817

3879

2.36

95.49

6.5

3.7

7.37

7.39

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

735

3350

2.43

94.07

2.5

2.1

0.18

0.20

g/l

16.54

672

3084

(3000991) Gas panel - Venous blood

715

3235

2.45

92.92

10.4

7.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

218

480

4.73

92.05

1.5

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2808

21061

1.92

89.87

8.5

4.7

6.95

6.90

mmol/l

0.50

2732

19830

(46235355) HIV 1 and 2 tests - Meaningful Use set

715

3290

2.40

89.24

1.8

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

623

2695

2.53

88.94

2.7

2.2

395.37

374.26

nmol/l

1.14

582

2444

(3002179) Metamyelocytes/100 leukocytes in Blood

595

2535

2.56

87.63

4.7

3.7

0.67

0.77

0.50

288

873

(3028026) IgM [Mass/volume] in Serum or Plasma

464

1759

2.83

86.06

2.2

1.9

1.29

1.38

g/l

0.32

425

1566

(3023419) Bacteria identified in Sputum by Culture

205

454

4.69

85.90

2.2

2.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

761

3656

2.31

85.75

9.8

7.0

116.22

120.14

g/l

5.82

747

3553

(3012501) Base excess in Blood by calculation

271

743

3.82

85.55

6.0

3.6

3.06

2.43

mmol/l

2.82

212

476

(3010421) pH of Blood

299

880

3.57

85.00

6.0

3.5

7.42

0.39

274

785

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

755

3653

2.29

83.48

4.1

2.8

378.78

244.42

ng/l

5.13

713

3351

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2075

14349

1.85

83.33

6.0

4.0

46.26

102.51

ng/l

1.12

1764

11028

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

541

2262

2.59

82.60

1.7

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

600

2661

2.45

80.73

5.2

3.8

0.10

0.11

0.18

289

880

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3283

26382

1.97

80.12

15.0

7.4

90.11

80.95

u/l

18.68

3164

24654

(3022313) Gas panel - Capillary blood

444

1706

2.78

80.07

6.4

3.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

198

457

4.49

78.77

1.9

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

562

2457

2.48

77.86

9.7

6.0

25.09

24.18

mmol/l

6.35

545

2336

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

259

735

3.68

77.67

1.4

1.8

10.54

12.52

mg/l

1.45

240

663

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1527

9764

1.86

77.31

2.9

2.2

3.46

3.03

mg/l

6.71

1324

8214

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1563

10086

1.85

76.72

5.0

3.1

41.07

38.25

u/l

0.36

1480

9518

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

352

1221

3.05

76.43

1.6

1.7

35.43

38.55

u/l

1.87

298

1030

(3027945) Reticulocytes/100 erythrocytes in Blood

908

4890

2.08

75.89

2.9

2.4

1.90

1.75

4.03

805

4259

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

210

526

4.14

75.07

1.7

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

210

526

4.14

75.07

1.7

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

227

602

3.92

75.03

6.1

4.5

251.10

4521.59

iu/ml

0.82

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1169

6910

1.94

74.94

2.1

1.7

1.77

1.54

mg/l

1.47

965

5352

(3025159) Blasts/100 leukocytes in Blood

558

2486

2.43

73.98

5.1

3.9

0.12

0.27

0.53

239

719

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

456

1854

2.63

73.36

6.2

3.9

24.12

23.90

mmol/l

0.78

442

1792

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

285

904

3.30

71.86

1.3

1.4

8.53

14.51

iu/ml

—

(40767503) Oxygen content in Capillary blood by calculation

254

757

3.50

70.66

3.5

2.2

14.77

16.15

5.29

136

383

(3026782) Osmolality of Urine

1252

7723

1.87

69.57

3.9

3.0

523.02

553.32

mosm/kgh2o

6.61

1118

6602

(3017143) Hepatitis C virus Ab [Presence] in Serum

576

2674

2.33

69.32

1.9

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

317

1094

3.05

69.31

1.5

417.14

238.55

titre

0.43

(3000494) Fungus identified in Specimen by Culture

725

3715

2.14

68.44

1.8

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

1658

11213

1.77

67.46

3.8

2.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

158

350

4.65

66.11

3.5

3.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

600

2890

2.25

65.97

1.9

1.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

633

3124

2.20

65.53

5.5

3.0

4.64

4.49

kpa

0.71

602

2998

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

185

472

4.05

64.45

6.4

6.3

12.38

12.22

mg/l

0.16

172

430

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

124

230

5.52

63.68

1.7

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

757

4043

2.05

63.62

2.1

1.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

582

2818

2.23

63.01

2.7

2.4

—

(3033658) Prothrombin time (PT) actual/Normal

1359

8827

1.78

62.47

8.4

3.9

80.23

84.07

6.06

1327

8613

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

157

365

4.42

61.83

2.0

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

369

1468

2.65

61.69

7.4

3.7

25.63

24.49

mmol/l

8.24

351

1317

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

456

2024

2.40

60.42

2.0

1.7

1.64

1.54

g/l

1.18

395

1711

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

453

2009

2.40

60.12

9.5

8.3

24.95

24.03

mmol/l

6.03

429

1916

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1184

7467

1.80

59.64

5.8

3.9

423.53

565.70

ng/l

0.40

1057

6406

(3015377) Calcium [Moles/volume] in Serum or Plasma

1729

12143

1.70

59.37

5.8

3.3

2.32

2.35

mmol/l

10.94

1546

10466

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2143

15937

1.67

59.12

3.9

2.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

275

961

2.99

58.66

4.0

2.7

25.38

24.40

mmol/l

2.81

269

937

(3028626) Oxygen [Partial pressure] in Capillary blood

255

855

3.10

58.46

4.8

2.7

7.69

7.94

kpa

1.53

250

828

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

300

1102

2.85

58.44

11.0

3.4

285.54

58.94

u/ml

2.98

294

1063

(3000850) Epithelial cells [#/volume] in Urine

1246

8032

1.77

57.97

3.4

2.7

5.21

4.45

e6/l

0.85

1149

7192

(3031040) Bacteria [#/volume] in Urine by Automated count

2851

22916

1.70

57.72

5.9

4.9

420.40

1795.40

e6/l

2.09

409

(3023520) Reticulocytes [#/volume] in Blood

688

3668

2.04

57.64

2.9

2.5

70.27

67.59

e9/l

1.00

525

2816

(3021879) Hepatitis B virus core Ab [Presence] in Serum

393

1673

2.48

56.97

1.4

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

1638

11438

1.69

56.79

4.4

3.4

59.07

97.77

e6/l

1.43

1362

8932

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

140

320

4.49

56.33

1.7

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

144

343

4.31

54.96

1.7

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

173

475

3.75

54.32

3.1

2.4

38890.36

2065.91

u/ml

0.46

(3023487) Leukocytes [#/volume] in Peritoneal fluid

117

7.03

53.34

2.1

2.2

6158.23

6962.03

e6/l

0.04

(40758558) Short blood count panel - Blood

1276

8442

1.72

53.31

12.9

6.3

—

(3030467) Casts [#/volume] in Urine by Automated count

1499

10356

1.68

53.29

4.3

3.3

0.57

0.46

e6/l

1.20

1248

8013

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1293

8588

1.72

53.24

3.5

2.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

444

2056

2.29

53.11

10.9

8.7

—

(3033799) Differential panel - Peritoneal fluid

103

7.49

52.97

1.9

2.0

—

(3021901) Oxygen saturation in Capillary blood

218

706

3.20

52.96

3.8

2.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

236

808

3.03

52.13

1.5

1.6

16.46

17.62

iu/ml

0.02

189

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

302

1186

2.66

51.62

1.4

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

106

207

5.22

51.44

1.8

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

252

905

2.89

51.09

3.1

2.5

3.66

3.59

g/l

0.28

242

854

(3015171) Extractable nuclear Ab [Units/volume] in Serum

264

975

2.82

50.82

1.3

1.2

0.92

0.43

u/ml

0.68

(36304419) Bacteria [Presence] in Urine

1440

9945

1.67

50.69

4.2

3.3

—

(3037756) Immunofixation for Serum or Plasma

247

884

2.90

50.39

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

172

5.62

50.08

1.8

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

173

5.59

49.77

1.8

1.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

496

2466

2.14

49.64

11.1

7.7

1.47

1.32

2.79

491

2449

(3018095) Leukocytes [#/volume] in Urine

1763

12880

1.62

49.18

5.1

3.9

158.75

113.48

e6/l

0.60

1416

9480

(3023183) Ammonium ion [Moles/volume] in Plasma

225

778

2.99

48.82

3.5

2.6

31.93

34.89

umol/l

0.95

203

684

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

689

3882

1.92

48.57

3.4

2.8

10.29

9.41

umol/l

0.43

593

3398

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

124

291

4.36

48.25

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

109

231

4.81

48.12

1.4

2.81

3.13

g/l

0.78

165

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

316

1314

2.51

47.97

3.5

3.3

2.07

2.91

ratio

0.39

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

490

2458

2.12

47.84

11.4

7.8

0.65

0.67

0.64

484

2438

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

320

1343

2.49

47.62

3.5

3.3

69.49

54.18

mg/l

0.36

257

1120

(3034860) Kappa light chains.free [Mass/volume] in Serum

320

1346

2.49

47.39

3.5

3.3

164.23

100.09

mg/l

0.27

258

1118

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

542

2836

2.04

47.22

5.8

3.8

129.53

97.71

ng/l

6.47

477

2418

(3024139) IgG subclass 3 [Mass/volume] in Serum

108

231

4.77

47.16

1.5

1.4

0.46

0.44

g/l

0.11

166

(3027135) IgG subclass 1 [Mass/volume] in Serum

108

231

4.77

47.16

1.5

1.4

7.13

6.97

g/l

0.14

166

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

478

2390

2.12

47.03

2.1

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

146

396

3.78

46.66

1.6

0.82

0.90

g/l

0.30

108

309

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

105

6.86

45.76

1.9

2.1

7289.11

23781.63

e6/l

0.49

(3026008) Bacteria identified in Urine by Culture

1571

11309

1.61

45.67

3.6

3.4

—

(4062490) Immunoglobulin typing, IgG

107

234

4.66

45.49

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

145

400

3.71

45.22

6.3

3.7

92.94

32.01

u/ml

3.23

140

386

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

115

269

4.36

44.94

1.9

1.4

—

(3044007) Cell count panel - Peritoneal fluid

7.40

44.90

2.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

673

3854

1.88

44.86

5.4

3.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

189

622

3.13

44.66

4.4

3.3

1.36

1.59

0.46

172

532

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1797

13412

1.58

44.44

4.3

2.8

227.31

156.99

ug/l

12.08

1660

12128

(40760888) Immunoglobulin light chains.free panel - Serum

256

997

2.66

44.41

3.2

3.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

173

542

3.28

44.35

1.6

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

229

844

2.81

44.20

2.3

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

134

357

3.84

43.94

1.7

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

134

357

3.84

43.94

1.7

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

119

292

4.16

43.69

1.7

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

119

292

4.16

43.69

1.7

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

119

292

4.16

43.69

1.7

1.5

—

(3021589) Normoblasts [#/volume] in Blood

1894

14346

1.56

43.66

18.7

9.6

0.00

e9/l

0.52

1577

11616

(3037692) Legionella sp identified in Specimen by Organism specific culture

7.08

43.18

1.6

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

650

3739

1.87

42.56

2.9

2.4

6.16

6.98

ug/l

0.75

560

3208

(3022806) Fractional oxyhemoglobin in Capillary blood

152

451

3.46

42.48

2.1

1.7

88.36

89.36

1.10

152

445

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

231

880

2.72

41.83

3.2

2.3

85.06

88.86

1.52

221

849

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

175

572

3.14

41.83

4.3

3.3

60.82

58.27

1.54

175

572

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

227

858

2.74

41.74

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

227

858

2.74

41.74

1.4

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2813

23436

1.56

41.06

6.0

4.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

465

2424

2.03

40.65

6.2

3.2

117.65

127.30

g/l

16.29

450

2355

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

348

1630

2.23

40.17

2.4

1.9

—

(3018405) Lactate [Moles/volume] in Arterial blood

312

1412

2.30

39.08

6.3

3.3

1.28

1.44

mmol/l

1.65

303

1387

(3002331) Protein [Mass/volume] in Peritoneal fluid

7.62

39.04

1.5

1.3

28.58

25.17

g/l

0.65

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

152

480

3.24

38.48

1.6

1.4

115.43

120.55

u/ml

0.20

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

343

1637

2.19

37.75

6.7

4.8

1.74

1.57

2.62

326

1539

(3047181) Lactate [Moles/volume] in Blood

272

1177

2.40

37.73

6.8

5.6

1.30

1.38

mmol/l

0.59

249

1046

(3007930) Methemoglobin/Hemoglobin.total in Blood

339

1611

2.20

37.71

6.8

4.8

0.85

0.87

0.57

323

1514

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

128

5.62

37.63

1.8

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

242

994

2.52

37.59

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

530

2971

1.89

37.31

6.3

3.6

1.21

1.22

mmol/l

3.47

494

2562

(3027273) Bicarbonate [Moles/volume] in Venous blood

394

1996

2.07

37.13

6.3

3.3

25.42

24.88

mmol/l

2.07

379

1929

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

130

5.53

37.01

1.8

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

128

5.54

36.55

1.8

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

166

4.83

35.28

3.3

3.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

223

4.24

35.24

2.3

—

(3020891) Body temperature

321

1542

2.17

34.70

8.6

4.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

315

1503

2.18

34.64

2.1

1.8

—

(4281824) Cell count and differential, peritoneal fluid

100

257

3.96

34.52

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

205

812

2.60

34.32

3.4

2.0

119.41

128.21

g/l

4.85

156

595

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

215

4.25

34.27

1.2

1.1

—

(3003181) Sodium [Moles/volume] in Urine

179

663

2.77

34.20

1.6

1.4

54.85

62.79

mmol/l

2.01

139

529

(3007164) IgA [Mass/volume] in Serum or Plasma

806

5245

1.66

33.57

1.8

1.5

2.98

2.67

g/l

2.99

547

3016

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

149

505

3.02

33.48

1.3

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2862

24423

1.49

33.32

6.0

4.0

21.48

13.67

mm/h

66.88

2663

22256

(3026493) Urate [Moles/volume] in Serum or Plasma

1300

9503

1.52

32.75

4.2

2.9

4070.05

5903.48

umol/l

0.78

1108

8115

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

6.78

32.66

1.1

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

264

3.81

32.47

1.2

1.1

—

u/ml

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

138

459

3.07

32.04

1.3

1.2

328.42

282.90

u/ml

0.90

283

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1489

11253

1.49

31.70

2.6

2.1

195.48

224.25

u/l

0.79

1407

10487

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

170

4.53

31.48

1.8

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

5.82

31.43

35.2

31.8

6.97

7.04

ug/l

0.08

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

201

824

2.51

31.34

3.2

2.4

224.66

200.93

3.03

195

779

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

534

3159

1.79

31.30

3.0

2.4

38.32

38.51

u/l

0.01

461

2692

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

144

500

2.94

31.01

1.3

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

219

940

2.40

30.90

3.3

3.0

0.86

0.81

nmol/l

0.80

166

693

(3019309) Folate [Moles/volume] in Red Blood Cells

1128

8086

1.53

30.78

2.1

1.8

1220.44

1158.64

nmol/l

1.23

879

5994

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

279

1329

2.17

30.76

2.7

2.2

471.45

700.58

ug/l

0.62

261

1261

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

170

4.47

30.57

1.8

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

357

1876

1.98

30.23

7.7

3.8

48.64

47.74

0.27

350

1847

(3007566) Smooth muscle Ab [Titer] in Serum

189

766

2.53

30.18

1.2

147.50

92.86

titre

0.31

(3026692) Albumin [Mass/volume] in Peritoneal fluid

5.95

29.92

1.4

1.5

15.16

13.40

g/l

0.65

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

292

1440

2.10

29.43

2.7

3.3

637.84

2948.63

u/ml

0.67

246

1239

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2344

19510

1.43

29.11

4.6

3.1

76.84

55.49

u/l

10.92

2158

17728

(3008757) Leukocyte morphology finding [Identifier] in Blood

126

421

3.05

29.05

6.0

3.8

—

(3036489) Thrombin time

246

1158

2.19

27.92

2.9

2.0

22.48

21.68

1.44

224

1055

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

313

1617

2.01

27.78

3.0

2.3

3.80

3.70

g/l

0.61

281

1433

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

313

1620

2.00

27.63

3.0

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

313

1621

2.00

27.58

3.0

2.3

7.63

7.38

g/l

1.70

284

1432

(3042733) HLA Ab [Presence] in Serum

6.53

27.24

3.7

5.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

297

1519

2.02

27.10

3.1

2.4

10.27

10.25

g/l

0.03

265

1316

(3043409) Potassium [Moles/volume] in Arterial blood

251

1209

2.14

26.88

7.3

3.5

4.00

3.92

mmol/l

1.73

246

1197

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

247

1189

2.14

26.49

3.1

2.3

0.03

0.04

g/l

0.19

221

1069

(3000012) Reticulocyte production index

156

615

2.59

26.40

2.2

—

(3039000) Anion gap in Blood

191

828

2.37

26.36

7.7

6.6

10.69

11.45

mmol/l

2.97

177

739

(3018572) Chloride [Moles/volume] in Blood

191

828

2.37

26.36

7.7

6.6

104.44

105.40

mmol/l

1.73

177

739

(3011412) CD3 cells [#/volume] in Blood

251

3.56

26.21

2.3

2.1

0.84

1.15

e9/l

3.08

225

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

291

1498

2.01

26.07

3.1

2.4

3.25

2.96

g/l

5.53

261

1313

(40761536) Microorganisms panel - Urine sediment

455

2707

1.76

25.94

5.6

4.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

161

651

2.53

25.86

1.3

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

112

375

3.04

25.76

1.6

—

(3037121) Protein [Mass/volume] in Urine

261

1302

2.07

25.48

3.4

3.2

0.62

0.33

g/l

1.97

132

540

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

983

7085

1.50

25.38

4.2

3.1

2.49

2.46

mmol/l

10.95

866

6155

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

10.43

25.34

1.1

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

232

1111

2.15

25.21

3.2

2.3

0.00

g/l

0.50

208

996

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

269

1363

2.04

25.17

3.1

2.5

0.74

1.16

g/l

1.45

230

1143

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

185

3.94

24.94

1.6

2.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

228

1090

2.15

24.89

3.2

2.4

0.00

g/l

-0.00

208

991

(3052851) Hemolysis interference index of Serum or Plasma

230

1105

2.14

24.79

4.3

3.3

—

(3024928) Oxygen saturation in Venous blood

182

799

2.33

24.42

4.8

2.8

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

181

798

2.32

24.05

3.2

3.1

454.19

726.67

u/ml

0.33

165

730

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

249

1253

2.05

23.74

3.2

2.2

34.80

37.34

g/l

8.63

219

1063

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

681

4606

1.57

23.40

1.3

59.10

37.84

iu/ml

1.71

225

1430

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

222

3.56

23.34

1.3

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

191

3.76

23.08

1.7

2.1

68.63

71.90

0.77

177

(4200892) Spirometry reversibility

379

2221

1.77

22.68

1.6

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

172

761

2.31

22.68

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

188

865

2.23

22.58

3.9

3.2

2.14

1.67

mg/l

6.84

174

761

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

186

3.70

21.60

4.6

3.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

122

4.39

21.26

30.3

24.7

118.90

114.07

ug/l

0.20

102

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

841

6061

1.48

21.25

4.0

3.1

1.77

1.85

e6/l

0.12

500

3460

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

159

701

2.32

21.15

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

106

389

2.77

20.71

4.4

3.3

60.76

56.20

1.17

310

(21494890) Protein electrophoresis panel - 24 hour Urine

115

441

2.65

20.63

2.6

1.9

—

(40768804) Tissue Pathology biopsy report

1621

13201

1.36

20.14

2.6

2.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

245

3.22

20.05

1.2

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1639

13379

1.36

20.03

2.7

2.2

78.10

78.43

nmol/l

0.17

1442

11670

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

6.44

19.63

10.0

13.2

5.73

5.40

mmol/l

0.14

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

153

690

2.26

19.32

1.4

1.2

3.48

2.98

u/ml

0.17

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

332

2.84

19.16

1.2

62.41

64.83

u/l

0.09

295

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

135

579

2.37

19.15

1.4

1.2

1.27

4.47

u/ml

0.90

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

160

738

2.21

19.14

1.4

1.2

31.08

45.63

u/ml

0.43

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

126

524

2.45

19.13

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

871

6435

1.44

19.10

3.7

3.0

1.21

1.18

e6/l

0.07

533

3792

(3019977) pH of Arterial blood

198

3.42

18.99

2.0

2.3

7.42

0.00

(21494814) CD8 cells/100 lymphocytes in Specimen

100

4.54

18.89

1.8

2.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

153

702

2.22

18.55

1.4

1.2

3.29

5.60

u/ml

0.74

106

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.65

18.19

1.7

2.0

—

(3035350) Ketones [Presence] in Urine by Test strip

1929

16298

1.33

18.12

4.9

3.9

0.00

estimate

2.17

509

3181

(40768446) Kidney Pathology biopsy report

112

4.23

18.08

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

222

3.19

17.75

1.1

176.00

116.92

titre

—

(3029937) Albumin [Presence] in Urine by Test strip

1143

8967

1.37

17.45

5.4

4.2

0.00

estimate

0.25

443

2744

(3021601) Nitrite [Presence] in Urine by Test strip

1916

16241

1.32

17.31

6.5

5.2

0.00

estimate

0.50

491

2915

(3025941) Bacteria identified in Stool by Culture

273

1576

1.78

17.15

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

1937

16460

1.32

17.12

5.0

3.9

0.00

estimate

1.08

477

2826

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3507

32487

1.39

16.76

38.6

16.2

33.06

27.35

mg/l

16.73

3313

26388

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

159

775

2.09

16.57

1.3

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

365

2.61

16.52

4.7

3.1

—

(3017569) Oxygen content in Arterial blood

172

3.40

16.40

1.9

—

(3014271) Vancomycin [Susceptibility]

244

2.98

16.34

2.5

3.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

109

457

2.42

16.31

2.9

2.3

1.49

1.32

g/24h

0.24

222

(3015736) pH of Urine

1575

13072

1.32

16.22

4.3

3.6

5.80

5.77

0.08

600

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

182

3.27

15.69

2.6

1.9

427.87

679.15

e6/l

2.50

175

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

400

2.48

15.56

1.1

1.72

1.52

g/l

2.81

357

(3000570) Elastase.pancreatic [Mass/mass] in Stool

188

1001

1.92

15.30

1.4

248.19

271.76

ug/g

0.80

113

596

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

104

442

2.39

15.13

1.4

1.5

404.60

198.22

pmol/l

1.70

432

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

199

3.09

14.81

1.7

1.6

7.57

7.75

u/l

0.03

159

(3039162) Centromere protein B Ab [Units/volume] in Serum

317

2.62

14.59

1.4

1.2

77.67

44.61

u/ml

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

266

2.77

14.56

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

272

2.75

14.52

1.4

—

(3051651) Icteric interference index of Serum or Plasma

207

3.02

14.48

5.9

3.3

—

(3013512) EKG study

1323

10855

1.31

14.39

6.1

4.3

—

(3000492) Spirometry study

391

2604

1.55

14.07

1.8

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

5.03

13.82

1.8

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

187

3.08

13.74

1.3

51.31

23.38

u/l

1.83

157

(3019225) pH of Specimen

532

3798

1.46

13.66

7.6

4.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

248

1493

1.70

13.45

1.4

1.3

193.61

233.44

u/ml

0.37

236

1368

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

200

2.98

13.45

1.5

1.4

22.47

29.11

u/l

1.02

159

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

101

447

2.29

13.44

1.0

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1049

8411

1.32

13.25

5.0

3.6

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

10.47

13.21

2.2

1.7

58.28

62.25

0.16

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

147

3.29

12.97

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

107

497

2.18

12.70

1.4

1.2

33.01

48.03

u/ml

0.51

(40768797) Stomach Pathology biopsy report

621

4619

1.40

12.66

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.77

12.58

1.1

1.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

197

2.92

12.58

1.3

1.2

144.56

96.10

u/l

1.57

168

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.63

12.57

1.1

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

171

3.07

12.51

2.3

2.5

35.75

37.43

0.22

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

590

4371

1.40

12.29

1.3

1.2

19.81

13.58

u/ml

0.89

199

1562

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

113

3.56

12.25

1.1

1.2

1.11

1.06

ratio

0.52

(3016650) Hepatitis A virus Ab [Presence] in Serum

427

2.25

12.23

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1834

15928

1.26

12.16

2.9

2.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

384

2.32

12.14

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

436

2.23

12.06

1.4

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

191

2.90

12.05

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

191

2.90

12.05

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

191

2.90

12.05

1.1

1.2

—

(3024471) HLA-A [Type]

4.13

12.03

1.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

11.05

12.01

1.9

1.5

8.18

23.00

0.90

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

386

2.31

12.00

1.3

1.2

4.27

3.20

u/ml

0.23

122

(3047189) Immunofixation for 24 hour Urine

203

2.83

11.93

2.2

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1131

9282

1.29

11.83

1.9

1.6

20.43

19.79

nmol/l

0.51

995

7829

(3044927) Protein electrophoresis panel - Urine

459

2.18

11.83

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

172

2.99

11.77

2.6

2.1

387.37

550.99

e6/l

1.41

146

(3024932) HLA-DR beta [Type]

4.16

11.77

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

216

2.76

11.74

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

205

2.80

11.72

1.7

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

205

2.80

11.72

1.7

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

194

2.86

11.72

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

194

2.86

11.72

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

194

2.86

11.72

1.1

—

(3004451) EKG impression Narrative

179

2.93

11.58

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

118

3.41

11.49

2.5

1.7

61.46

65.17

ug/l

0.08

113

(3009214) Lutropin [Units/volume] in Serum or Plasma

109

531

2.08

11.48

1.4

13.14

10.00

u/l

1.16

421

(3028433) Virus identified in Specimen by Culture

3.66

11.48

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

165

2.99

11.35

2.7

2.1

0.18

0.23

e9/l

1.09

145

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

467

2.15

11.34

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

141

756

1.89

11.32

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

248

1566

1.62

11.21

3.6

3.2

4.04

4.40

pmol/l

5.37

212

1351

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

994

8084

1.30

11.03

1.8

1.7

27569366.36

23467942.47

pmol/l

0.09

798

6558

(3042111) Morphology [Interpretation] in Bone marrow Narrative

133

712

1.90

10.75

1.7

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

166

2.91

10.63

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1456

12455

1.25

10.60

5.4

4.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

229

2.60

10.52

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.43

10.39

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.75

10.29

1.9

1.3

—

(3008295) Osmolality of Serum or Plasma

357

2.24

10.11

1.4

267.91

277.55

mosm/kgh2o

2.78

266

(3040151) Glucose [Moles/volume] in Capillary blood

458

2.08

9.95

7.4

10.5

6.65

7.70

mmol/l

3.06

369

(3006922) Hepatitis E virus Ab [Presence] in Serum

168

2.82

9.83

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

197

2.66

9.75

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

197

2.66

9.75

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

121

655

1.87

9.49

1.4

1.3

40.41

44.34

u/l

0.17

105

566

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

381

2.15

9.42

1.3

1.2

4.68

5.49

u/ml

0.16

168

(40768441) Liver Pathology biopsy report

202

2.59

9.30

1.7

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

158

2.80

9.15

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

158

2.80

9.15

1.1

1.0

—

(3017732) Neutrophils [#/volume] in Blood

304

2106

1.48

9.07

3.9

3.2

6.16

5.75

e9/l

0.13

230

1578

(40757494) Bilirubin.total [Moles/volume] in Blood

206

2.54

8.95

2.6

2.1

15.00

32.77

umol/l

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

466

2.00

8.81

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

460

2.00

8.77

1.6

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

151

2.80

8.73

1.5

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3044

32279

0.81

8.58

5.2

5.3

2.41

2.57

mmol/l

18.63

2671

29144

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

458

1.99

8.52

1.6

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

458

1.99

8.52

1.6

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2919

31075

0.82

8.50

4.7

1.36

1.41

mmol/l

9.04

2570

28002

(3017704) Immunofixation for Urine

242

2.37

8.48

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

459

1.98

8.47

1.6

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2953

31391

0.82

8.41

4.8

4.7

4.21

4.43

mmol/l

22.49

2617

28506

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

195

2.53

8.38

2.8

1.9

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

461

1.97

8.37

1.6

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

344

2.11

8.10

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

983

8249

1.25

8.09

1.4

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

131

2.84

7.94

2.8

2.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.43

7.89

1.3

1.1

—

(21494434) Karyotype in Bone marrow

348

2.09

7.87

1.3

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.59

7.84

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

175

1111

1.60

7.83

1.6

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

535

1.85

7.57

1.2

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

384

2872

1.37

7.48

1.8

1.7

1.75

1.57

3.20

311

2427

(3048879) Bone marrow aspiration report

119

2.87

7.47

1.8

1.4

—

(3011985) Renin [Units/volume] in Plasma

425

1.95

7.42

1.6

1.4

88.68

63.63

mu/l

0.48

377

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

102

569

1.81

7.36

4.7

2.9

—

(3051611) Lipemic interference index of Serum or Plasma

386

1.99

7.29

5.3

3.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

145

904

1.62

7.02

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

232

2.26

6.98

1.9

1.2

—

(40761535) Cells panel - Urine sediment

412

3158

1.34

6.84

4.6

3.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1749

15731

1.19

6.82

2.4

2.1

91.97

91.95

pmol/l

0.01

993

8256

(3033705) Calcium.ionized [Moles/volume] in Venous blood

561

1.78

6.82

4.1

2.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

146

919

1.61

6.81

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.63

6.74

2.0

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

145

914

1.61

6.73

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

426

1.89

6.72

1.5

65.43

63.65

0.17

260

(40757373) Influenza virus identified in Isolate

3.22

6.69

1.9

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

330

2.02

6.65

1.2

1.1

111.32

113.24

0.18

297

(3004616) Nuclear Ab [Presence] in Serum

365

1.96

6.62

1.4

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

212

2.28

6.61

1.6

1.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

280

2035

1.40

6.51

2.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

365

2774

1.34

6.43

4.6

2.7

52.83

61.54

ml/min/173m2

4.55

198

1171

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

268

2.10

6.36

2.1

1.8

5266.78

2038.11

u/l

0.40

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

100

1660

0.59

6.30

1.7

1.8

—

(3052592) Norovirus Ag [Presence] in Stool

3.17

6.28

1.3

—

(21494755) Public health laboratory ask at order entry panel

1432

0.56

6.26

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.67

6.19

1.2

1.8

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.92

6.15

1.6

1.8

1.89

1.96

umol/l

0.16

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.92

6.15

1.4

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

254

2.10

6.01

2.2

2.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

140

2.51

6.01

1.3

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.02

5.99

1.8

2.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

393

1.87

5.97

1.1

1.4

257.30

299.63

pmol/l

0.61

330

(3044889) 12 lead EKG panel

2549

23802

1.17

5.93

5.7

4.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.90

5.88

1.4

1.3

—

(3021788) Differential panel - Synovial fluid

105

636

1.67

5.76

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.18

5.69

2.8

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1058

0.52

5.63

1.4

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.19

5.58

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

730

8582

0.82

5.49

1.7

1.6

1.37

1.32

mmol/l

0.78

595

7142

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

7.07

5.43

4.8

2.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

167

2.29

5.36

3.5

2.7

53.79

70.51

mg/l

1.35

115

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.92

5.29

4.0

1.9

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

302

1.93

5.29

1.4

1.6

—

1226.67

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.13

5.18

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

147

990

1.50

5.17

1.4

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

2868

27158

1.16

5.17

43.1

19.3

15.78

15.28

5.42

2823

26584

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

164

2.27

5.13

1.4

1.3

0.26

1.82

u/ml

1.46

(3014148) Varicella zoster virus Ab [Titer] in Serum

223

2.07

5.12

1.1

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

115

2.53

5.11

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

115

2.53

5.11

2.2

2.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

911

7909

1.19

5.07

4.3

3.8

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

10.02

5.02

1.0

1.44

1.11

u/field

—

(3002256) Pathology report gross observation

549

4546

1.24

4.96

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.67

4.92

3.1

5.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

268

1.95

4.91

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

442

1.73

4.90

1.2

1.3

231.58

225.68

miu/ml

0.03

150

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.64

4.81

2.9

2.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2868

30083

0.87

4.80

4.3

4.2

1.29

1.28

mmol/l

0.21

2511

26819

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

257

1.96

4.77

1.4

1.2

—

(40768795) Lymph node Pathology biopsy report

307

1.87

4.74

1.4

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

337

1.82

4.69

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

346

1.80

4.61

1.6

1.4

23.26

25.58

0.25

220

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

4.53

4.55

3.2

3.9

67.86

61.76

ug/min

0.07

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.16

4.48

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

5.80

4.43

1.2

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2922

30523

0.87

4.28

7.1

6.5

41.94

40.89

mmol/mol

5.87

2600

27753

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.96

4.27

1.1

—

(1761868) Lipid panel - Serum or Plasma

820

9341

0.85

4.21

3.4

3.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

120

812

1.49

4.20

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

4.81

4.18

1.3

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

2.67

4.15

1.1

104.81

91.91

0.48

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

103

2.44

4.13

1.7

102.23

97.48

umol/l

0.05

(3036525) Urea [Moles/time] in 24 hour Urine

5.89

4.12

2.6

3.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.54

4.12

7.0

7.8

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

4.34

4.12

2.8

4.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.67

3.98

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

2.60

3.97

1.0

—

(3002619) Bacteria identified in Specimen by Culture

2.82

3.95

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

791

0.55

3.86

1.6

1.7

6.13

3.67

mg/l

0.56

587

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

228

1.89

3.81

1.0

303.91

285.94

mg/l

0.77

198

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

293

1.78

3.81

1.0

1.1

—

2.22

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.60

3.80

6.1

8.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.60

3.80

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.60

3.80

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.60

3.80

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.60

3.80

1.3

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

160

2.07

3.76

1.5

11.50

6.19

u/l

0.45

140

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

679

5894

1.18

3.73

1.3

1.2

0.88

1.72

u/ml

5.39

158

1503

(3020682) Albumin/Creatinine [Ratio] in Urine

1319

12027

1.14

3.71

4.4

3.8

25.86

9.02

mg/mmol

10.18

891

7717

(3009871) Measles virus Ab [Titer] in Serum

2.86

3.62

1.4

1.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

269

1.79

3.60

1.2

1.1

91.23

93.23

0.22

250

(21491868) Cryoglobulin [Mass/volume] in Serum

117

2.23

3.57

1.7

1.2

0.24

0.33

g/l

—

(40761511) CBC panel - Blood by Automated count

3422

33132

1.15

3.55

34.9

15.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

637

1.50

3.53

1.3

—

(3011648) Oxygen content in Venous blood

271

1.78

3.52

3.3

2.3

10.78

10.85

0.03

271

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

354

1.68

3.50

1.2

1.3

—

nmol/l

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

4.24

3.50

3.1

2.9

1.43

1.13

mg/l

0.28

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.71

3.48

6.2

7.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3525

34213

1.15

3.48

43.1

19.5

138.51

139.63

mmol/l

86.17

3450

33263

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

112

2.24

3.47

1.3

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

378

1.65

3.47

1.3

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

163

1212

1.36

3.45

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.76

3.38

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.10

3.36

1.1

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

436

1.59

3.36

1.8

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

153

1133

1.36

3.33

5.1

4.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

860

9602

0.87

3.30

3.0

3.3

0.81

0.83

ug/l

0.15

624

6852

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

197

1.89

3.29

2.3

2.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

169

1.96

3.28

1.5

1.4

2.75

3.53

—

(40765096) Chromosome analysis panel by Banding

115

2.18

3.28

1.2

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

220

1.83

3.22

1.6

1.3

1.04

1.10

promille

0.11

174

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.67

3.22

1.6

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

2.58

3.21

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1246

13558

0.89

3.19

4.4

4.7

21.99

22.27

0.25

671

7160

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.86

3.19

1.2

213.00

1634.26

ng/l

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3525

34277

1.14

3.13

43.5

19.7

4.05

4.01

mmol/l

16.09

3443

33278

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

216

1.81

3.09

1.6

1.7

—

(3034426) Prothrombin time (PT)

2.33

3.07

1.4

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

375

3144

1.21

3.05

2.0

2.1

210.16

163.94

ug/g

1.06

304

2446

(40758292) HTLV I+II Ab panel - Serum

3.18

3.05

1.2

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

5.01

3.05

1.0

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3067

31710

0.89

3.04

5.2

5.0

6.24

6.10

mmol/l

4.64

2678

28262

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

174

1.90

3.04

1.0

1.1

233.89

305.25

mg/l

1.71

146

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

10.01

2.98

1.6

2.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

183

1.86

2.95

1.1

34.24

46.03

mg/l

1.47

149

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.47

2.95

4.2

3.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

411

1.57

2.95

1.2

1.3

0.34

0.28

nmol/l

—

(3004775) Volume in Urine collected for unspecified duration

326

1.63

2.92

1.7

2.2

698.29

641.49

0.43

196

(3046861) Legionella sp Ag [Presence] in Urine

4.71

2.91

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

128

2.04

2.91

1.5

—

(40768443) Skin Pathology biopsy report

198

1556

1.29

2.89

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

2.22

2.89

2.3

1.9

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

518

1.50

2.89

2.0

1.7

346.22

298.73

mu/l

0.81

478

(3000060) B lymphocytes [#/volume] in Blood

2.59

2.87

1.5

2.3

160.00

309.52

e6/l

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

129

2.02

2.85

1.0

1.16

1.21

u/l

0.10

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.45

2.79

1.4

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

4.45

2.79

1.4

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

134

1003

1.35

2.78

2.1

2.2

187.13

96.73

ug/min

1.03

582

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

638

1.44

2.78

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

483

1.50

2.75

1.7

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

145

1.94

2.74

1.3

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.01

2.72

5.3

7.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

2.37

2.72

2.0

1.6

2.23

4.91

ug/l

0.68

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2466

23580

1.10

2.72

4.3

3.7

15.24

15.00

pmol/l

4.24

2191

20918

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

242

1.70

2.66

1.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

161

1.87

2.66

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.33

2.64

1.3

1.1

—

(3016750) Collection duration of Urine

220

1.73

2.64

1.6

1.9

500.31

488.16

min

0.14

154

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

629

1.42

2.62

1.8

1.7

4.58

4.42

iu/l

0.04

192

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

247

2998

0.81

2.57

1.6

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

1254

11612

1.11

2.57

3.8

3.2

6.74

7.42

mmol/l

7.27

1018

9573

(3016018) Differential panel - Cerebral spinal fluid

283

1.63

2.57

1.3

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

626

0.60

2.53

1.7

—

(3036180) Methadone [Presence] in Urine

2.50

2.52

2.0

1.6

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.98

2.48

3.5

1.8

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

4.38

2.47

12.6

9.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.81

2.46

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

374

1.53

2.45

1.2

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

505

1.45

2.43

2.5

2.0

34.65

25.11

mg/l

0.67

118

(3044941) Cell count panel - Synovial fluid

555

1.43

2.43

1.5

1.4

—

(3012516) Albumin [Mass/volume] in Urine

1225

11372

1.11

2.37

3.8

3.3

533.13

305.02

mg/l

0.95

858

7410

(1002224) Polysomnography panel

913

0.69

2.34

1.0

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

114

860

1.33

2.30

1.6

19088.09

15274.06

e6/l

0.25

604

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

126

1.91

2.30

1.0

1.1

108.80

451.00

ng/l

—

(4094501) Cardiovascular stress test using bicycle ergometer

909

0.69

2.29

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.38

2.29

1.2

—

(3049717) Cytology report of Urine Cyto stain

225

1854

1.23

2.25

2.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

120

1.92

2.25

3.2

2.4

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.56

2.21

5.0

592.60

357.00

umol/l

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.56

2.21

1.4

1.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

459

1.44

2.18

6.0

4.2

361.05

343.66

umol/l

0.46

386

(3020393) Adenovirus Ag [Presence] in Stool

3.00

2.14

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

797

0.69

2.08

1.5

1.7

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

736

1.34

2.07

1.4

1.3

514.89

592.44

mg/l

0.74

687

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.91

2.07

2.3

2.0

21.29

17.59

umol/l

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.91

2.07

1.8

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.08

2.06

1.5

1.6

2093.65

168.32

nmol/24h

0.49

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.50

2.05

1.1

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

222

1.63

2.05

13.2

15.0

—

(36660697) Celiac disease serology panel - Serum

249

2098

1.20

2.01

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.82

2.00

2.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.82

2.00

2.2

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.82

2.00

2.2

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

578

1.37

1.99

1.3

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.08

1.96

1.4

10.37

9.24

ug/l

0.47

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.75

1.93

2.3

2.6

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.75

1.93

2.8

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

143

1.75

1.88

1.2

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.19

1.88

1.1

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

236

1.57

1.86

3.0

2.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

130

1033

1.27

1.85

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

161

1.68

1.78

1.1

2.0

21.95

13.85

umol/l

0.26

102

(40768800) Prostate Pathology biopsy report

1121

0.76

1.73

1.1

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

234

2735

0.85

1.71

1.3

1.4

—

(3020491) Glucose [Moles/volume] in Blood

250

1.52

1.70

1.9

1.8

7.70

6.90

mmol/l

0.90

160

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.91

1.69

1.2

0.34

0.30

g/l

1.02

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

630

1.32

1.69

1.5

24052.23

707.50

e6/l

0.48

517

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

630

1.32

1.69

1.4

37.64

24.74

e6/l

0.17

495

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3490

34234

1.09

1.67

20.1

10.8

24.91

25.67

u/l

1.11

3379

32679

(3045424) Erythrocytes [Presence] in Urine

554

1.34

1.66

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.16

1.66

1.3

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.16

1.66

1.3

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

180

1.62

1.66

2.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

335

1.44

1.63

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.57

1.61

3.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

134

0.37

1.60

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

134

0.37

1.60

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

134

0.37

1.60

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

134

0.37

1.60

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

198

1.57

1.59

1.7

1.9

17.20

16.22

nmol/l

0.18

181

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

160

1.63

1.55

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.97

1.53

1.1

1.3

—

(3003338) MCHC [Mass/volume]

2540

26146

0.93

1.52

48.5

21.8

328.45

332.00

g/l

60.53

2500

25843

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

140

0.43

1.52

1.2

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

146

1.65

1.50

1.5

1.2

138.87

141.23

nmol/l

0.08

146

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.90

1.49

2.7

2.2

142.80

137.94

nmol/l

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.44

1.47

1.1

1.5

36.33

45.95

umol/l

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

3.13

1.44

1.6

1.8

2.20

1.47

—

(3022475) Manganese [Moles/volume] in Blood

3.13

1.44

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.25

1.40

1.1

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

356

1.38

1.37

1.4

1.3

67960.90

101950.35

e6/l

0.32

251

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.94

1.36

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

654

1.27

1.34

1.3

4.31

3.88

mmol/l

1.38

599

(3000764) Benzodiazepines [Presence] in Urine

376

1.36

1.32

2.1

1.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

325

1.39

1.31

1.3

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.50

1.30

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.00

1.27

1.8

1.7

—

(3019150) Specific gravity of Urine by Refractometry

790

7392

1.08

1.27

5.2

4.3

1.02

kg/l

0.32

125

1141

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.29

1.26

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.40

1.24

1.2

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.40

1.24

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

100

1.70

1.23

1.4

2.1

—

(3028300) Cannabinoids [Presence] in Urine

381

1.34

1.23

2.1

1.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.04

1.22

2.1

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

289

1.39

1.19

2.0

1.9

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

281

1.39

1.18

1.2

1.4

343.33

202.94

titre

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

223

0.58

1.15

1.3

1.5

—

(3019174) dRVVT (LA screen)

2.50

1.15

1.2

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

207

1.45

1.15

2.0

1.8

1.45

2.31

u/field

0.63

148

(3027008) Opiates [Presence] in Urine

378

1.33

1.13

2.1

1.9

—

(40768793) Breast Pathology biopsy report

537

1.27

1.12

1.4

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.34

1.12

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.00

1.12

1.0

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

353

1.34

1.12

1.8

2.1

1.95

1.83

u/field

0.09

132

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

293

1.37

1.11

1.3

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

336

1.34

1.11

1.8

1.7

33.50

25.76

u/ml

0.54

(3027944) Amphetamines [Presence] in Urine

372

1.32

1.09

2.1

1.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

175

2006

0.87

1.08

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

172

1495

1.16

1.08

1.2

100.94

135.57

iu/ml

0.59

515

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.87

1.07

1.5

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.79

1.04

2.4

1.6

167.58

158.53

ng/l

0.06

(3038177) Helicobacter pylori Ab [Presence] in Serum

402

1.30

1.03

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.06

1.02

1.1

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

130

1.54

1.02

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.92

1.02

2.2

2.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3093

30392

1.06

1.01

34.3

15.8

71.13

73.73

ml/min/173m2

7.21

2749

25163

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.88

1.00

2.2

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

107

1262

0.84

0.98

1.1

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.67

0.97

1.0

1.1

1732.00

1611.44

miu/ml

0.12

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

224

1.39

0.96

1.8

2.2

64.73

197.80

ug/min

0.67

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

363

1.30

0.95

1.1

—

9.16

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.62

0.93

1.4

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

1.67

0.91

2.2

1.7

1.14

1.19

mmol/l

1.88

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.82

0.85

1.0

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.82

0.85

1.0

1.2

—

(44813793) Dust mix specific IgE antibody measurement

153

1.44

0.85

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

524

1.22

0.83

1.4

1.3

25.66

30.87

iu/l

0.68

444

(4146454) Self-monitoring of blood glucose

444

1.24

0.82

2.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.88

0.81

1.0

1.1

7.83

11.47

u/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

499

4682

1.07

0.80

15.2

8.2

—

(4034850) Laboratory test

1097

0.85

0.80

18.3

11.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.79

0.0

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.62

0.78

1.3

1.2

79.08

92.38

0.48

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.77

0.0

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.76

0.0

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.08

0.74

1.4

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

194

1753

1.11

0.73

1.3

43.33

66.16

au/ml

—

101

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.62

0.71

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

353

1.25

0.71

2.3

1.9

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

168

1.37

0.71

1.3

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

490

1.21

0.70

1.1

109.34

60.56

iu/ml

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

532

0.81

0.70

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

693

1.17

0.70

1.8

1.5

1.00

0.83

nmol/l

0.51

561

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

443

0.79

0.69

1.3

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

169

1.36

0.69

1.3

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

145

0.62

0.69

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

262

0.72

0.68

1.1

1.0

54.59

44.34

ng/l

0.45

158

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

262

0.72

0.68

1.1

1.0

749.00

660.27

ng/l

—

157

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1640

16827

0.96

0.67

5.0

5.4

5.19

4.19

ug/l

0.20

1391

14934

(3022145) Colonoscopy Study observation

391

3665

1.07

0.67

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

260

0.73

0.66

1.1

1.0

567.08

313.67

ng/l

0.73

160

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

1.72

0.64

1.4

1.1

—

15.17

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

244

1.27

0.61

1.1

1.03

4.55

u/ml

2.98

116

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.57

0.60

1.0

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2972

29340

1.04

0.60

5.2

4.6

2.45

2.07

mu/l

0.74

2642

26199

(3036670) Protein [Mass/volume] in Synovial fluid

122

1.39

0.60

1.3

1.2

34.10

40.32

g/l

1.80

(3011288) Drugs identified in Urine by Screen method

254

1.26

0.59

2.3

2.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

399

1.21

0.59

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.67

0.56

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

167

1.32

0.56

2.3

1.5

—

(3006270) Folate [Moles/volume] in Blood

339

1.21

0.54

1.0

1.2

335.68

332.21

nmol/l

0.03

266

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

125

1.36

0.53

1.1

1.4

1.55

1.54

g/l

0.06

125

(3014051) Protein [Presence] in Urine by Test strip

951

0.88

0.53

3.0

2.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

211

1956

1.08

0.52

2.5

2.4

9.80

23.65

au/ml

—

108

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.50

0.51

1.3

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

191

0.73

0.50

1.2

1.4

114.74

204.79

pmol/l

1.00

191

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

699

1.13

0.48

1.1

9.54

9.17

u/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

155

0.71

0.48

1.6

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.40

0.48

3.4

2.0

0.80

1.30

ug/l

0.95

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

128

1403

0.91

0.48

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

190

1.26

0.47

1.2

1.5

0.10

0.24

nmol/l

3.48

149

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.49

0.47

1.0

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.46

0.46

2.6

1.43

0.31

u/field

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

111

1.35

0.46

1.1

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

182

1.27

0.46

1.2

1.3

1.49

1.16

nmol/l

0.56

135

(3024263) Appearance of Synovial fluid

210

0.76

0.46

1.8

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.40

0.45

1.0

1.2

—

(3023410) Appearance of Cerebral spinal fluid

274

1.21

0.44

1.6

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

157

1.28

0.43

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

174

0.75

0.43

1.2

1.0

10.68

2.05

u/ml

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.41

0.43

2.2

2.1

181.45

206.59

0.52

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.61

0.43

1.0

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

239

1.21

0.42

1.1

0.33

1.92

u/ml

1.51

101

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.52

0.41

1.0

1.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.05

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.03

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

159

1.26

0.40

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

1.41

0.39

1.3

1.4

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.39

0.0

1.0

—

125.57

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.4

—

0.87

—

(1617658) Protocol used for examination of sentinel lymph nodes

187

1.23

0.38

1.0

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.39

0.38

1.8

1.4

24.88

20.77

mmol/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.39

0.38

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.35

0.37

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.35

0.37

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

351

3358

1.05

0.37

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.35

0.37

1.4

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.33

0.35

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

458

4414

1.04

0.35

4.7

4.8

33.60

33.06

0.44

324

2879

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.40

0.35

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

163

1.23

0.34

1.8

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

133

0.75

0.33

1.3

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

118

1.27

0.33

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.69

0.33

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

0.67

0.32

1.2

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.30

0.30

2.1

2.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.33

0.30

1.6

1.1

—

(3000330) Specific gravity of Urine by Test strip

212

2020

1.05

0.29

5.5

3.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

161

0.81

0.27

7.2

6.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

113

1.24

0.26

1.1

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

224

0.85

0.25

5.6

5.1

11.68

37.87

u/ml

—

(3051101) Glucose [Moles/volume] in Cord blood

1.18

0.24

3.2

5.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.25

0.24

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.74

0.24

1.2

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

124

1.21

0.24

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

227

1.15

0.23

1.5

1.6

118.31

95.39

umol/l

0.32

227

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

284

1.13

0.23

1.1

0.43

1.64

u/ml

2.16

145

(3001729) Color of Synovial fluid

1.32

0.23

2.2

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.74

0.22

1.3

1.6

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

3.12

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.3

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.04

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.23

0.21

1.0

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

3548

35339

1.02

0.21

53.8

24.2

37.58

39.61

58.14

3268

32492

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.10

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.20

0.19

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.13

0.18

1.7

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.13

0.18

2.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.13

0.18

2.2

2.6

—

78.56

au/ml

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.21

0.18

1.3

1.1

—

(3007461) Platelets [#/volume] in Blood

3548

35356

1.02

0.18

53.5

24.1

249.21

238.32

e9/l

13.21

3459

34219

(3010813) Leukocytes [#/volume] in Blood

3549

35369

1.02

0.17

53.5

24.1

7.47

6.89

e9/l

19.89

3451

34087

(3035941) MCH [Entitic mass]

3548

35361

1.02

0.17

53.2

24.0

30.23

30.49

11.74

3480

34644

(3024731) MCV [Entitic volume]

3548

35361

1.02

0.17

53.3

24.0

91.96

91.68

2.60

3480

34643

(3026361) Erythrocytes [#/volume] in Blood

3548

35363

1.02

0.16

53.5

24.1

4.18

4.42

e12/l

116.62

3455

34084

(3008898) HLA-B27 [Presence]

680

0.94

0.16

1.0

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

3548

35370

1.02

0.15

53.9

24.2

124.81

133.91

g/l

181.15

3486

34661

(3015183) Erythrocyte sedimentation rate

0.83

0.13

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

100

0.80

0.13

1.1

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

117

1213

0.96

0.13

1.6

1.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

540

1.06

0.13

1.5

1.8

3.38

4.72

mmol/24h

2.84

458

(3032773) Endomysium IgG Ab [Titer] in Serum

219

1.10

0.12

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

168

0.89

0.11

3.9

4.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

757

0.96

0.09

2.0

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

472

0.95

0.09

1.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

126

1.11

0.09

1.9

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1.09

0.08

3.2

2.2

9.66

8.66

mg/l

—

(3045414) Leukocytes [Presence] in Urine

156

1526

1.02

0.08

2.1

1.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

134

0.90

0.08

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.04

0.07

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

157

1.08

0.07

1.2

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

129

1.09

0.05

1.1

1.3

126.21

161.60

mmol/24h

1.53

129

(3016244) Insulin [Units/volume] in Serum or Plasma

110

0.91

0.05

1.9

3.0

52.14

18.72

mu/l

—

103

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

313

0.96

0.05

1.0

1.1

3.90

2.31

u/ml

—

104

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

171

0.94

0.05

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

210

1.05

0.03

1.1

1.11

1.47

u/ml

0.13

107

(3022621) pH of Urine by Test strip

241

2391

1.01

0.03

3.4

3.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

110

1090

1.01

0.01

1.5

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

127

0.94

0.01

1.8

2.7

28.67

29.40

umol/l

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

271

2699

1.00

0.01

2.1

10.84

12.00

nmol/l

1.21

222

2321

(3000034) Microalbumin [Mass/volume] in Urine

364

1.02

0.00

3.2

60.07

34.53

mg/l

0.39

280

(3051387) C reactive protein [Mass/volume] in Capillary blood

854

1.01

0.00

4.1

3.6

33.53

31.06

mg/l

0.23

553

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

195

1.03

0.00

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.03

0.00

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

123

0.98

0.00

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

133

0.98

0.00

1.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

266

1.02

0.00

1.5

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

269

1.00

0.00

1.5

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.1

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

5.7

—

(3000285) Sodium [Moles/volume] in Blood

0.89

-0.00

1.2

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.1

—

1.29

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

370

1.00

-0.00

1.8

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.85

-0.00

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.96

-0.00

1.0

1.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

32.80

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.98

-0.00

2.8

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_PLEUROTH and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_PLEUROTH	5.148 [4.33, 6.12]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 4491 out of 7479 females with J10_PLEUROTH died.

Males

Parameter	HR [95% CI]	p-value
J10_PLEUROTH	3.722 [3.21, 4.31]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.017

During the follow-up period (1.1.1998 — 31.12.2019), 6334 out of 11188 males with J10_PLEUROTH died.

Mortality risk

Mortality risk for people of age

years, who have J10_PLEUROTH.

N-year risk	Females	Males
1	0.428%	0.56%
5	2.282%	4.013%
10	5.981%	9.919%
15	11.678%	18.879%
20	19.82%	31.195%

Relationships between endpoints

↥

Index endpoint: J10_PLEUROTH – Other pleural conditions

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other pleural conditions

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints